GO Terms |
Score |
Description |
GO:0008150 |
99.04% |
biological_process |
GO:0065007 |
98.40% |
biological regulation |
GO:0050789 |
98.15% |
regulation of biological process |
GO:0050794 |
97.06% |
regulation of cellular process |
GO:0031323 |
96.23% |
regulation of cellular metabolic process |
GO:0080090 |
95.89% |
regulation of primary metabolic process |
GO:0019222 |
95.58% |
regulation of metabolic process |
GO:0051171 |
95.36% |
regulation of nitrogen compound metabolic process |
GO:0051246 |
95.12% |
regulation of protein metabolic process |
GO:0060255 |
94.81% |
regulation of macromolecule metabolic process |
GO:0032268 |
94.59% |
regulation of cellular protein metabolic process |
GO:0065009 |
92.39% |
regulation of molecular function |
GO:0051247 |
91.76% |
positive regulation of protein metabolic process |
GO:0031399 |
91.73% |
regulation of protein modification process |
GO:0009987 |
91.71% |
cellular process |
GO:0032270 |
90.87% |
positive regulation of cellular protein metabolic process |
GO:0050790 |
90.85% |
regulation of catalytic activity |
GO:0051174 |
90.62% |
regulation of phosphorus metabolic process |
GO:0019220 |
90.32% |
regulation of phosphate metabolic process |
GO:0043269 |
89.66% |
regulation of ion transport |
GO:0071280 |
89.58% |
cellular response to copper ion |
GO:0031325 |
89.49% |
positive regulation of cellular metabolic process |
GO:0043525 |
89.40% |
positive regulation of neuron apoptotic process |
GO:0051173 |
89.24% |
positive regulation of nitrogen compound metabolic process |
GO:1901216 |
89.08% |
positive regulation of neuron death |
GO:1903959 |
88.98% |
regulation of anion transmembrane transport |
GO:0048518 |
88.86% |
positive regulation of biological process |
GO:0031401 |
88.81% |
positive regulation of protein modification process |
GO:0016043 |
88.71% |
cellular component organization |
GO:0048522 |
88.68% |
positive regulation of cellular process |
GO:0001932 |
88.60% |
regulation of protein phosphorylation |
GO:0042325 |
88.11% |
regulation of phosphorylation |
GO:0071840 |
88.06% |
cellular component organization or biogenesis |
GO:0010604 |
87.98% |
positive regulation of macromolecule metabolic process |
GO:0046688 |
87.96% |
response to copper ion |
GO:0009893 |
87.82% |
positive regulation of metabolic process |
GO:0044093 |
87.61% |
positive regulation of molecular function |
GO:0010562 |
87.51% |
positive regulation of phosphorus metabolic process |
GO:0031648 |
87.47% |
protein destabilization |
GO:0045937 |
87.19% |
positive regulation of phosphate metabolic process |
GO:0051049 |
87.14% |
regulation of transport |
GO:0043085 |
87.06% |
positive regulation of catalytic activity |
GO:0050896 |
86.75% |
response to stimulus |
GO:1904646 |
86.22% |
cellular response to amyloid-beta |
GO:0045859 |
86.00% |
regulation of protein kinase activity |
GO:0034765 |
85.75% |
regulation of ion transmembrane transport |
GO:0019722 |
85.56% |
calcium-mediated signaling |
GO:0032879 |
85.48% |
regulation of localization |
GO:0043549 |
85.13% |
regulation of kinase activity |
GO:1901653 |
84.86% |
cellular response to peptide |
GO:0042327 |
84.84% |
positive regulation of phosphorylation |
GO:0044070 |
84.45% |
regulation of anion transport |
GO:0051338 |
84.39% |
regulation of transferase activity |
GO:0065008 |
84.29% |
regulation of biological quality |
GO:0035556 |
84.27% |
intracellular signal transduction |
GO:0061098 |
84.25% |
positive regulation of protein tyrosine kinase activity |
GO:0032409 |
84.17% |
regulation of transporter activity |
GO:1904645 |
84.07% |
response to amyloid-beta |
GO:0010941 |
84.06% |
regulation of cell death |
GO:0034762 |
83.60% |
regulation of transmembrane transport |
GO:0022898 |
83.49% |
regulation of transmembrane transporter activity |
GO:0051259 |
83.41% |
protein complex oligomerization |
GO:0043067 |
83.27% |
regulation of programmed cell death |
GO:0061097 |
83.22% |
regulation of protein tyrosine kinase activity |
GO:0033674 |
83.18% |
positive regulation of kinase activity |
GO:0071417 |
83.00% |
cellular response to organonitrogen compound |
GO:0010038 |
82.90% |
response to metal ion |
GO:0043523 |
82.88% |
regulation of neuron apoptotic process |
GO:0042981 |
82.87% |
regulation of apoptotic process |
GO:0051260 |
82.80% |
protein homooligomerization |
GO:0051347 |
82.79% |
positive regulation of transferase activity |
GO:0032412 |
82.74% |
regulation of ion transmembrane transporter activity |
GO:0042221 |
82.67% |
response to chemical |
GO:1901214 |
82.66% |
regulation of neuron death |
GO:0001934 |
82.57% |
positive regulation of protein phosphorylation |
GO:0045860 |
82.50% |
positive regulation of protein kinase activity |
GO:0051716 |
82.18% |
cellular response to stimulus |
GO:0007165 |
81.85% |
signal transduction |
GO:0071495 |
81.76% |
cellular response to endogenous stimulus |
GO:0043933 |
81.17% |
protein-containing complex subunit organization |
GO:0070887 |
81.03% |
cellular response to chemical stimulus |
GO:0019932 |
80.34% |
second-messenger-mediated signaling |
GO:0071248 |
80.29% |
cellular response to metal ion |
GO:0043065 |
80.04% |
positive regulation of apoptotic process |
GO:0010035 |
79.97% |
response to inorganic substance |
GO:0010942 |
79.94% |
positive regulation of cell death |
GO:0071310 |
79.88% |
cellular response to organic substance |
GO:1901700 |
79.76% |
response to oxygen-containing compound |
GO:1901699 |
79.34% |
cellular response to nitrogen compound |
GO:0010033 |
79.08% |
response to organic substance |
GO:0009719 |
78.89% |
response to endogenous stimulus |
GO:0043068 |
78.69% |
positive regulation of programmed cell death |
GO:0031647 |
78.55% |
regulation of protein stability |
GO:0010243 |
78.49% |
response to organonitrogen compound |
GO:0071241 |
78.31% |
cellular response to inorganic substance |
GO:1901698 |
78.17% |
response to nitrogen compound |
GO:1901701 |
77.78% |
cellular response to oxygen-containing compound |
GO:1901652 |
77.69% |
response to peptide |
GO:0065003 |
77.50% |
protein-containing complex assembly |
GO:0022607 |
76.53% |
cellular component assembly |
GO:0042130 |
76.40% |
negative regulation of T cell proliferation |
GO:0010522 |
75.81% |
regulation of calcium ion transport into cytosol |
GO:0050868 |
75.31% |
negative regulation of T cell activation |
GO:0050858 |
75.05% |
negative regulation of antigen receptor-mediated signaling pathway |
GO:0048583 |
74.98% |
regulation of response to stimulus |
GO:0070884 |
74.88% |
regulation of calcineurin-NFAT signaling cascade |
GO:0050672 |
74.65% |
negative regulation of lymphocyte proliferation |
GO:0032945 |
74.34% |
negative regulation of mononuclear cell proliferation |
GO:0051250 |
74.32% |
negative regulation of lymphocyte activation |
GO:0048519 |
74.25% |
negative regulation of biological process |
GO:1903038 |
74.20% |
negative regulation of leukocyte cell-cell adhesion |
GO:0090314 |
74.16% |
positive regulation of protein targeting to membrane |
GO:0070664 |
74.14% |
negative regulation of leukocyte proliferation |
GO:0009966 |
74.12% |
regulation of signal transduction |
GO:0046006 |
74.03% |
regulation of activated T cell proliferation |
GO:0023051 |
74.01% |
regulation of signaling |
GO:0010959 |
74.01% |
regulation of metal ion transport |
GO:0106056 |
73.99% |
regulation of calcineurin-mediated signaling |
GO:0050849 |
73.81% |
negative regulation of calcium-mediated signaling |
GO:0010646 |
73.66% |
regulation of cell communication |
GO:0022408 |
73.54% |
negative regulation of cell-cell adhesion |
GO:1904377 |
73.34% |
positive regulation of protein localization to cell periphery |
GO:0090313 |
73.22% |
regulation of protein targeting to membrane |
GO:0051924 |
73.20% |
regulation of calcium ion transport |
GO:0050866 |
73.17% |
negative regulation of cell activation |
GO:1902531 |
72.82% |
regulation of intracellular signal transduction |
GO:0050856 |
72.75% |
regulation of T cell receptor signaling pathway |
GO:0050730 |
72.71% |
regulation of peptidyl-tyrosine phosphorylation |
GO:0007162 |
72.62% |
negative regulation of cell adhesion |
GO:1903078 |
72.55% |
positive regulation of protein localization to plasma membrane |
GO:0002695 |
72.47% |
negative regulation of leukocyte activation |
GO:0042129 |
72.41% |
regulation of T cell proliferation |
GO:0032660 |
72.05% |
regulation of interleukin-17 production |
GO:0048523 |
71.85% |
negative regulation of cellular process |
GO:1902003 |
71.85% |
regulation of amyloid-beta formation |
GO:1905477 |
71.79% |
positive regulation of protein localization to membrane |
GO:0050854 |
71.60% |
regulation of antigen receptor-mediated signaling pathway |
GO:0032944 |
71.38% |
regulation of mononuclear cell proliferation |
GO:0050670 |
71.06% |
regulation of lymphocyte proliferation |
GO:0060341 |
70.92% |
regulation of cellular localization |
GO:1903076 |
70.86% |
regulation of protein localization to plasma membrane |
GO:0050731 |
70.77% |
positive regulation of peptidyl-tyrosine phosphorylation |
GO:0070663 |
70.75% |
regulation of leukocyte proliferation |
GO:1903037 |
70.57% |
regulation of leukocyte cell-cell adhesion |
GO:2001141 |
70.56% |
regulation of RNA biosynthetic process |
GO:0006355 |
70.33% |
regulation of transcription, DNA-templated |
GO:1901379 |
70.17% |
regulation of potassium ion transmembrane transport |
GO:0090279 |
70.13% |
regulation of calcium ion import |
GO:0002694 |
70.08% |
regulation of leukocyte activation |
GO:1904375 |
70.07% |
regulation of protein localization to cell periphery |
GO:0050865 |
70.04% |
regulation of cell activation |
GO:0050863 |
69.88% |
regulation of T cell activation |
GO:1904062 |
69.81% |
regulation of cation transmembrane transport |
GO:0043266 |
69.64% |
regulation of potassium ion transport |
GO:1903169 |
69.63% |
regulation of calcium ion transmembrane transport |
GO:1903506 |
69.56% |
regulation of nucleic acid-templated transcription |
GO:0022407 |
69.54% |
regulation of cell-cell adhesion |
GO:1905809 |
69.40% |
negative regulation of synapse organization |
GO:0031324 |
69.25% |
negative regulation of cellular metabolic process |
GO:1900449 |
69.14% |
regulation of glutamate receptor signaling pathway |
GO:0046686 |
69.10% |
response to cadmium ion |
GO:1900271 |
69.04% |
regulation of long-term synaptic potentiation |
GO:0032663 |
68.82% |
regulation of interleukin-2 production |
GO:0051249 |
68.80% |
regulation of lymphocyte activation |
GO:0032689 |
68.79% |
negative regulation of interferon-gamma production |
GO:1902991 |
68.73% |
regulation of amyloid precursor protein catabolic process |
GO:0106027 |
68.55% |
neuron projection organization |
GO:0051172 |
68.42% |
negative regulation of nitrogen compound metabolic process |
GO:1903533 |
68.41% |
regulation of protein targeting |
GO:0009892 |
68.41% |
negative regulation of metabolic process |
GO:0009889 |
68.08% |
regulation of biosynthetic process |
GO:0051252 |
68.01% |
regulation of RNA metabolic process |
GO:0019219 |
67.99% |
regulation of nucleobase-containing compound metabolic process |
GO:0032147 |
67.90% |
activation of protein kinase activity |
GO:0032269 |
67.81% |
negative regulation of cellular protein metabolic process |
GO:0050848 |
67.76% |
regulation of calcium-mediated signaling |
GO:2000112 |
67.72% |
regulation of cellular macromolecule biosynthetic process |
GO:0044092 |
67.63% |
negative regulation of molecular function |
GO:0010556 |
67.40% |
regulation of macromolecule biosynthetic process |
GO:1905475 |
67.36% |
regulation of protein localization to membrane |
GO:0010605 |
67.29% |
negative regulation of macromolecule metabolic process |
GO:0051050 |
67.15% |
positive regulation of transport |
GO:0031326 |
66.97% |
regulation of cellular biosynthetic process |
GO:0051248 |
66.85% |
negative regulation of protein metabolic process |
GO:0051239 |
66.53% |
regulation of multicellular organismal process |
GO:0031400 |
66.47% |
negative regulation of protein modification process |
GO:0048585 |
66.27% |
negative regulation of response to stimulus |
GO:0032649 |
66.23% |
regulation of interferon-gamma production |
GO:0002683 |
66.13% |
negative regulation of immune system process |
GO:0009968 |
66.08% |
negative regulation of signal transduction |
GO:0099175 |
66.02% |
regulation of postsynapse organization |
GO:0030155 |
65.78% |
regulation of cell adhesion |
GO:1904951 |
65.64% |
positive regulation of establishment of protein localization |
GO:1902532 |
65.58% |
negative regulation of intracellular signal transduction |
GO:0034249 |
65.51% |
negative regulation of cellular amide metabolic process |
GO:0032880 |
65.51% |
regulation of protein localization |
GO:0043433 |
65.28% |
negative regulation of DNA-binding transcription factor activity |
GO:0010468 |
64.87% |
regulation of gene expression |
GO:0051090 |
64.46% |
regulation of DNA-binding transcription factor activity |
GO:0051222 |
64.45% |
positive regulation of protein transport |
GO:1903827 |
64.34% |
regulation of cellular protein localization |
GO:0001933 |
64.34% |
negative regulation of protein phosphorylation |
GO:0008285 |
64.05% |
negative regulation of cell population proliferation |
GO:0010648 |
64.04% |
negative regulation of cell communication |
GO:0006950 |
64.04% |
response to stress |
GO:0023057 |
64.02% |
negative regulation of signaling |
GO:1903829 |
63.69% |
positive regulation of cellular protein localization |
GO:0051128 |
63.63% |
regulation of cellular component organization |
GO:0045936 |
63.53% |
negative regulation of phosphate metabolic process |
GO:0048167 |
63.21% |
regulation of synaptic plasticity |
GO:0010563 |
62.89% |
negative regulation of phosphorus metabolic process |
GO:0002682 |
62.88% |
regulation of immune system process |
GO:0032501 |
62.66% |
multicellular organismal process |
GO:0051129 |
62.64% |
negative regulation of cellular component organization |
GO:0009410 |
61.77% |
response to xenobiotic stimulus |
GO:0042326 |
61.76% |
negative regulation of phosphorylation |
GO:0042127 |
61.63% |
regulation of cell population proliferation |
GO:0032388 |
61.62% |
positive regulation of intracellular transport |
GO:0003008 |
61.48% |
system process |
GO:0050807 |
61.16% |
regulation of synapse organization |
GO:0001818 |
61.12% |
negative regulation of cytokine production |
GO:0050890 |
61.04% |
cognition |
GO:0050877 |
60.86% |
nervous system process |
GO:0051241 |
60.64% |
negative regulation of multicellular organismal process |
GO:0090316 |
60.61% |
positive regulation of intracellular protein transport |
GO:0006979 |
60.41% |
response to oxidative stress |
GO:0032386 |
60.41% |
regulation of intracellular transport |
GO:0007611 |
60.29% |
learning or memory |
GO:0060548 |
60.05% |
negative regulation of cell death |
GO:0050776 |
59.97% |
regulation of immune response |
GO:0070201 |
59.96% |
regulation of establishment of protein localization |
GO:0043069 |
59.91% |
negative regulation of programmed cell death |
GO:0043066 |
59.67% |
negative regulation of apoptotic process |
GO:0090087 |
59.32% |
regulation of peptide transport |
GO:0034248 |
58.92% |
regulation of cellular amide metabolic process |
GO:0051223 |
58.85% |
regulation of protein transport |
GO:0033157 |
58.53% |
regulation of intracellular protein transport |
GO:0031345 |
58.53% |
negative regulation of cell projection organization |
GO:0050804 |
58.29% |
modulation of chemical synaptic transmission |
GO:0099177 |
58.01% |
regulation of trans-synaptic signaling |
GO:0071466 |
57.30% |
cellular response to xenobiotic stimulus |
GO:0120035 |
56.97% |
regulation of plasma membrane bounded cell projection organization |
GO:0031344 |
56.60% |
regulation of cell projection organization |
GO:0007610 |
56.03% |
behavior |
GO:0001817 |
55.48% |
regulation of cytokine production |
GO:0120036 |
55.18% |
plasma membrane bounded cell projection organization |
GO:0048878 |
54.60% |
chemical homeostasis |
GO:0042592 |
54.16% |
homeostatic process |
GO:0006875 |
53.06% |
cellular metal ion homeostasis |
GO:0030030 |
52.97% |
cell projection organization |
GO:0050801 |
52.32% |
ion homeostasis |
GO:0055082 |
51.89% |
cellular chemical homeostasis |
GO:0006873 |
51.86% |
cellular ion homeostasis |
GO:0030003 |
51.85% |
cellular cation homeostasis |
GO:0019725 |
51.30% |
cellular homeostasis |
GO:0055065 |
51.06% |
metal ion homeostasis |
GO:0098771 |
50.74% |
inorganic ion homeostasis |
GO:0046916 |
50.12% |
cellular transition metal ion homeostasis |
GO:0055080 |
49.94% |
cation homeostasis |
GO:0006878 |
49.64% |
cellular copper ion homeostasis |
GO:0055070 |
48.67% |
copper ion homeostasis |
GO:0055076 |
44.59% |
transition metal ion homeostasis |
GO:0043086 |
43.67% |
negative regulation of catalytic activity |
GO:0010629 |
29.92% |
negative regulation of gene expression |
GO:0007049 |
29.50% |
cell cycle |
GO:0099173 |
28.02% |
postsynapse organization |
GO:1903318 |
27.90% |
negative regulation of protein maturation |
GO:0010955 |
27.81% |
negative regulation of protein processing |
GO:0030162 |
27.65% |
regulation of proteolysis |
GO:0070613 |
27.51% |
regulation of protein processing |
GO:0007616 |
27.43% |
long-term memory |
GO:1903317 |
27.33% |
regulation of protein maturation |
GO:0097061 |
27.04% |
dendritic spine organization |
GO:0043954 |
25.59% |
cellular component maintenance |
GO:0007613 |
24.07% |
memory |
GO:0008152 |
24.03% |
metabolic process |
GO:0045861 |
23.85% |
negative regulation of proteolysis |
GO:0044237 |
21.93% |
cellular metabolic process |
GO:0071704 |
21.11% |
organic substance metabolic process |
GO:0006807 |
20.73% |
nitrogen compound metabolic process |
GO:0044238 |
19.31% |
primary metabolic process |
GO:0023056 |
18.99% |
positive regulation of signaling |
GO:0010647 |
18.92% |
positive regulation of cell communication |
GO:0048584 |
18.06% |
positive regulation of response to stimulus |
GO:0034641 |
17.98% |
cellular nitrogen compound metabolic process |
GO:0006139 |
17.90% |
nucleobase-containing compound metabolic process |
GO:1901360 |
17.82% |
organic cyclic compound metabolic process |
GO:1902533 |
17.66% |
positive regulation of intracellular signal transduction |
GO:0006725 |
17.52% |
cellular aromatic compound metabolic process |
GO:0043270 |
17.50% |
positive regulation of ion transport |
GO:0046483 |
17.37% |
heterocycle metabolic process |
GO:0009967 |
16.91% |
positive regulation of signal transduction |
GO:0051282 |
15.76% |
regulation of sequestering of calcium ion |
GO:0006996 |
15.51% |
organelle organization |
GO:0006357 |
15.31% |
regulation of transcription by RNA polymerase II |
GO:0044057 |
14.80% |
regulation of system process |
GO:0006874 |
14.53% |
cellular calcium ion homeostasis |
GO:0043408 |
14.28% |
regulation of MAPK cascade |
GO:0012501 |
14.04% |
programmed cell death |
GO:0051179 |
13.84% |
localization |
GO:0006915 |
13.77% |
apoptotic process |
GO:0090257 |
13.76% |
regulation of muscle system process |
GO:0007204 |
13.74% |
positive regulation of cytosolic calcium ion concentration |
GO:0051928 |
13.72% |
positive regulation of calcium ion transport |
GO:0051336 |
13.70% |
regulation of hydrolase activity |
GO:0097190 |
13.66% |
apoptotic signaling pathway |
GO:0055074 |
13.66% |
calcium ion homeostasis |
GO:0051345 |
13.61% |
positive regulation of hydrolase activity |
GO:0008219 |
13.51% |
cell death |
GO:0034767 |
13.43% |
positive regulation of ion transmembrane transport |
GO:0051279 |
13.43% |
regulation of release of sequestered calcium ion into cytosol |
GO:0034764 |
13.07% |
positive regulation of transmembrane transport |
GO:0061024 |
12.97% |
membrane organization |
GO:0043410 |
12.69% |
positive regulation of MAPK cascade |
GO:0048147 |
12.65% |
negative regulation of fibroblast proliferation |
GO:0072503 |
12.48% |
cellular divalent inorganic cation homeostasis |
GO:1904064 |
12.43% |
positive regulation of cation transmembrane transport |
GO:0042391 |
12.41% |
regulation of membrane potential |
GO:0050793 |
12.39% |
regulation of developmental process |
GO:0051480 |
12.09% |
regulation of cytosolic calcium ion concentration |
GO:0010524 |
12.01% |
positive regulation of calcium ion transport into cytosol |
GO:0051234 |
12.01% |
establishment of localization |
GO:0007166 |
11.96% |
cell surface receptor signaling pathway |
GO:0006937 |
11.93% |
regulation of muscle contraction |
GO:0080134 |
11.92% |
regulation of response to stress |
GO:0051051 |
11.92% |
negative regulation of transport |
GO:0014070 |
11.85% |
response to organic cyclic compound |
GO:0009628 |
11.83% |
response to abiotic stimulus |
GO:0072507 |
11.79% |
divalent inorganic cation homeostasis |
GO:0010558 |
11.67% |
negative regulation of macromolecule biosynthetic process |
GO:0032984 |
11.63% |
protein-containing complex disassembly |
GO:0032870 |
11.59% |
cellular response to hormone stimulus |
GO:2000026 |
11.54% |
regulation of multicellular organismal development |
GO:0033993 |
11.49% |
response to lipid |
GO:0045862 |
11.41% |
positive regulation of proteolysis |
GO:0045934 |
11.29% |
negative regulation of nucleobase-containing compound metabolic process |
GO:0051240 |
11.27% |
positive regulation of multicellular organismal process |
GO:0051047 |
11.14% |
positive regulation of secretion |
GO:0006810 |
11.10% |
transport |
GO:0051726 |
11.05% |
regulation of cell cycle |
GO:1902679 |
11.05% |
negative regulation of RNA biosynthetic process |
GO:0008283 |
11.02% |
cell population proliferation |
GO:0010950 |
11.01% |
positive regulation of endopeptidase activity |
GO:0048145 |
10.96% |
regulation of fibroblast proliferation |
GO:0002691 |
10.95% |
regulation of cellular extravasation |
GO:0051668 |
10.94% |
localization within membrane |
GO:2001056 |
10.94% |
positive regulation of cysteine-type endopeptidase activity |
GO:1903507 |
10.93% |
negative regulation of nucleic acid-templated transcription |
GO:0051130 |
10.93% |
positive regulation of cellular component organization |
GO:0008104 |
10.89% |
protein localization |
GO:2000113 |
10.81% |
negative regulation of cellular macromolecule biosynthetic process |
GO:0045892 |
10.79% |
negative regulation of transcription, DNA-templated |
GO:0033036 |
10.79% |
macromolecule localization |
GO:0035304 |
10.73% |
regulation of protein dephosphorylation |
GO:0032502 |
10.66% |
developmental process |
GO:0002693 |
10.62% |
positive regulation of cellular extravasation |
GO:1903532 |
10.53% |
positive regulation of secretion by cell |
GO:0009725 |
10.43% |
response to hormone |
GO:0008625 |
10.37% |
extrinsic apoptotic signaling pathway via death domain receptors |
GO:0010952 |
10.37% |
positive regulation of peptidase activity |
GO:0009890 |
10.36% |
negative regulation of biosynthetic process |
GO:0010907 |
10.34% |
positive regulation of glucose metabolic process |
GO:0033554 |
10.25% |
cellular response to stress |
GO:0051270 |
10.24% |
regulation of cellular component movement |
GO:0043113 |
10.19% |
receptor clustering |
GO:0080135 |
10.18% |
regulation of cellular response to stress |
GO:0031327 |
10.15% |
negative regulation of cellular biosynthetic process |
GO:0032233 |
10.08% |
positive regulation of actin filament bundle assembly |
GO:0034097 |
10.08% |
response to cytokine |
GO:0051281 |
10.07% |
positive regulation of release of sequestered calcium ion into cytosol |
GO:0042493 |
10.04% |
response to drug |
GO:0060627 |
10.03% |
regulation of vesicle-mediated transport |
GO:0044087 |
10.01% |
regulation of cellular component biogenesis |
GO:1904427 |
10.01% |
positive regulation of calcium ion transmembrane transport |
GO:0051649 |
9.97% |
establishment of localization in cell |
GO:0051253 |
9.96% |
negative regulation of RNA metabolic process |
GO:0045932 |
9.93% |
negative regulation of muscle contraction |
GO:0035303 |
9.90% |
regulation of dephosphorylation |
GO:0031589 |
9.85% |
cell-substrate adhesion |
GO:0009605 |
9.79% |
response to external stimulus |
GO:0051094 |
9.78% |
positive regulation of developmental process |
GO:0051592 |
9.78% |
response to calcium ion |
GO:0050869 |
9.67% |
negative regulation of B cell activation |
GO:0043122 |
9.66% |
regulation of I-kappaB kinase/NF-kappaB signaling |
GO:0035307 |
9.66% |
positive regulation of protein dephosphorylation |
GO:0071887 |
9.60% |
leukocyte apoptotic process |
GO:0007160 |
9.60% |
cell-matrix adhesion |
GO:0045786 |
9.51% |
negative regulation of cell cycle |
GO:0055117 |
9.47% |
regulation of cardiac muscle contraction |
GO:0006811 |
9.47% |
ion transport |
GO:2001233 |
9.46% |
regulation of apoptotic signaling pathway |
GO:0002376 |
9.41% |
immune system process |
GO:0035306 |
9.41% |
positive regulation of dephosphorylation |
GO:0050678 |
9.38% |
regulation of epithelial cell proliferation |
GO:0043123 |
9.37% |
positive regulation of I-kappaB kinase/NF-kappaB signaling |
GO:0007169 |
9.34% |
transmembrane receptor protein tyrosine kinase signaling pathway |
GO:0070555 |
9.33% |
response to interleukin-1 |
GO:0009636 |
9.33% |
response to toxic substance |
GO:0045822 |
9.28% |
negative regulation of heart contraction |
GO:0051046 |
9.26% |
regulation of secretion |
GO:0045597 |
9.23% |
positive regulation of cell differentiation |
GO:1901890 |
9.18% |
positive regulation of cell junction assembly |
GO:0051926 |
9.18% |
negative regulation of calcium ion transport |
GO:0042542 |
9.17% |
response to hydrogen peroxide |
GO:0031398 |
9.12% |
positive regulation of protein ubiquitination |
GO:0044089 |
9.06% |
positive regulation of cellular component biogenesis |
GO:0050806 |
9.05% |
positive regulation of synaptic transmission |
GO:0048856 |
8.93% |
anatomical structure development |
GO:0008016 |
8.93% |
regulation of heart contraction |
GO:0045595 |
8.92% |
regulation of cell differentiation |
GO:0006469 |
8.87% |
negative regulation of protein kinase activity |
GO:0033673 |
8.86% |
negative regulation of kinase activity |
GO:0031952 |
8.84% |
regulation of protein autophosphorylation |
GO:0050864 |
8.78% |
regulation of B cell activation |
GO:0031396 |
8.73% |
regulation of protein ubiquitination |
GO:0048646 |
8.72% |
anatomical structure formation involved in morphogenesis |
GO:1903793 |
8.71% |
positive regulation of anion transport |
GO:0071396 |
8.71% |
cellular response to lipid |
GO:0043547 |
8.67% |
positive regulation of GTPase activity |
GO:0051100 |
8.65% |
negative regulation of binding |
GO:0043271 |
8.63% |
negative regulation of ion transport |
GO:0048869 |
8.59% |
cellular developmental process |
GO:1903530 |
8.54% |
regulation of secretion by cell |
GO:0055081 |
8.53% |
anion homeostasis |
GO:0043280 |
8.52% |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0104004 |
8.49% |
cellular response to environmental stimulus |
GO:0032231 |
8.48% |
regulation of actin filament bundle assembly |
GO:0007010 |
8.47% |
cytoskeleton organization |
GO:0043409 |
8.45% |
negative regulation of MAPK cascade |
GO:0000302 |
8.42% |
response to reactive oxygen species |
GO:0032410 |
8.42% |
negative regulation of transporter activity |
GO:0007507 |
8.39% |
heart development |
GO:0043666 |
8.38% |
regulation of phosphoprotein phosphatase activity |
GO:0070372 |
8.38% |
regulation of ERK1 and ERK2 cascade |
GO:0048545 |
8.38% |
response to steroid hormone |
GO:0010676 |
8.36% |
positive regulation of cellular carbohydrate metabolic process |
GO:0097193 |
8.35% |
intrinsic apoptotic signaling pathway |
GO:0043254 |
8.35% |
regulation of protein complex assembly |
GO:0000122 |
8.35% |
negative regulation of transcription by RNA polymerase II |
GO:0030001 |
8.34% |
metal ion transport |
GO:0071214 |
8.30% |
cellular response to abiotic stimulus |
GO:0070838 |
8.26% |
divalent metal ion transport |
GO:0051348 |
8.23% |
negative regulation of transferase activity |
GO:1903322 |
8.23% |
positive regulation of protein modification by small protein conjugation or removal |
GO:0040012 |
8.22% |
regulation of locomotion |
GO:0006952 |
8.19% |
defense response |
GO:0033043 |
8.19% |
regulation of organelle organization |
GO:0007154 |
8.19% |
cell communication |
GO:0019221 |
8.19% |
cytokine-mediated signaling pathway |
GO:0031644 |
8.18% |
regulation of nervous system process |
GO:1903523 |
8.12% |
negative regulation of blood circulation |
GO:0009607 |
8.10% |
response to biotic stimulus |
GO:0034612 |
8.09% |
response to tumor necrosis factor |
GO:0098655 |
8.08% |
cation transmembrane transport |
GO:0018105 |
8.08% |
peptidyl-serine phosphorylation |
GO:0009896 |
8.08% |
positive regulation of catabolic process |
GO:0034220 |
8.07% |
ion transmembrane transport |
GO:2001235 |
8.06% |
positive regulation of apoptotic signaling pathway |
GO:0045765 |
8.05% |
regulation of angiogenesis |
GO:0010874 |
8.03% |
regulation of cholesterol efflux |
GO:0006816 |
7.99% |
calcium ion transport |
GO:1903522 |
7.98% |
regulation of blood circulation |
GO:1901983 |
7.98% |
regulation of protein acetylation |
GO:0050821 |
7.98% |
protein stabilization |
GO:0032414 |
7.97% |
positive regulation of ion transmembrane transporter activity |
GO:0006919 |
7.95% |
activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0043087 |
7.95% |
regulation of GTPase activity |
GO:1905954 |
7.94% |
positive regulation of lipid localization |
GO:0006812 |
7.92% |
cation transport |
GO:0007167 |
7.90% |
enzyme linked receptor protein signaling pathway |
GO:0009894 |
7.90% |
regulation of catabolic process |
GO:0022610 |
7.90% |
biological adhesion |
GO:0071392 |
7.87% |
cellular response to estradiol stimulus |
GO:0031056 |
7.86% |
regulation of histone modification |
GO:0007155 |
7.85% |
cell adhesion |
GO:0072511 |
7.85% |
divalent inorganic cation transport |
GO:0009314 |
7.80% |
response to radiation |
GO:0051641 |
7.80% |
cellular localization |
GO:0010639 |
7.77% |
negative regulation of organelle organization |
GO:0022411 |
7.77% |
cellular component disassembly |
GO:0010564 |
7.76% |
regulation of cell cycle process |
GO:0010880 |
7.76% |
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum |
GO:0051898 |
7.76% |
negative regulation of protein kinase B signaling |
GO:0032411 |
7.74% |
positive regulation of transporter activity |
GO:0051091 |
7.73% |
positive regulation of DNA-binding transcription factor activity |
GO:2000145 |
7.73% |
regulation of cell motility |
GO:0052548 |
7.72% |
regulation of endopeptidase activity |
GO:0070848 |
7.71% |
response to growth factor |
GO:0086004 |
7.70% |
regulation of cardiac muscle cell contraction |
GO:2001025 |
7.68% |
positive regulation of response to drug |
GO:1903320 |
7.68% |
regulation of protein modification by small protein conjugation or removal |
GO:0048872 |
7.67% |
homeostasis of number of cells |
GO:0048513 |
7.67% |
animal organ development |
GO:0032370 |
7.67% |
positive regulation of lipid transport |
GO:0097435 |
7.66% |
supramolecular fiber organization |
GO:0035148 |
7.66% |
tube formation |
GO:0097191 |
7.66% |
extrinsic apoptotic signaling pathway |
GO:0051098 |
7.65% |
regulation of binding |
GO:1903115 |
7.62% |
regulation of actin filament-based movement |
GO:0051496 |
7.59% |
positive regulation of stress fiber assembly |
GO:0071900 |
7.59% |
regulation of protein serine/threonine kinase activity |
GO:0031329 |
7.59% |
regulation of cellular catabolic process |
GO:0090280 |
7.58% |
positive regulation of calcium ion import |
GO:0016055 |
7.57% |
Wnt signaling pathway |
GO:0010975 |
7.56% |
regulation of neuron projection development |
GO:0070232 |
7.55% |
regulation of T cell apoptotic process |
GO:0022603 |
7.51% |
regulation of anatomical structure morphogenesis |
GO:0097746 |
7.50% |
regulation of blood vessel diameter |
GO:0031058 |
7.48% |
positive regulation of histone modification |
GO:0051272 |
7.47% |
positive regulation of cellular component movement |
GO:0070849 |
7.45% |
response to epidermal growth factor |
GO:0031331 |
7.44% |
positive regulation of cellular catabolic process |
GO:1902275 |
7.43% |
regulation of chromatin organization |
GO:1902105 |
7.42% |
regulation of leukocyte differentiation |
GO:0001525 |
7.40% |
angiogenesis |
GO:0052547 |
7.39% |
regulation of peptidase activity |
GO:0032413 |
7.38% |
negative regulation of ion transmembrane transporter activity |
GO:0051894 |
7.38% |
positive regulation of focal adhesion assembly |
GO:0023052 |
7.36% |
signaling |
GO:0030002 |
7.36% |
cellular anion homeostasis |
GO:0046887 |
7.36% |
positive regulation of hormone secretion |
GO:0031334 |
7.32% |
positive regulation of protein complex assembly |
GO:0009891 |
7.31% |
positive regulation of biosynthetic process |
GO:0007517 |
7.30% |
muscle organ development |
GO:0007267 |
7.25% |
cell-cell signaling |
GO:0070374 |
7.25% |
positive regulation of ERK1 and ERK2 cascade |
GO:0032387 |
7.25% |
negative regulation of intracellular transport |
GO:1905114 |
7.24% |
cell surface receptor signaling pathway involved in cell-cell signaling |
GO:0097306 |
7.21% |
cellular response to alcohol |
GO:0034763 |
7.20% |
negative regulation of transmembrane transport |
GO:0006974 |
7.20% |
cellular response to DNA damage stimulus |
GO:0071345 |
7.18% |
cellular response to cytokine stimulus |
GO:0031638 |
7.16% |
zymogen activation |
GO:2000756 |
7.15% |
regulation of peptidyl-lysine acetylation |
GO:0008284 |
7.15% |
positive regulation of cell population proliferation |
GO:1902884 |
7.15% |
positive regulation of response to oxidative stress |
GO:0070228 |
7.11% |
regulation of lymphocyte apoptotic process |
GO:0046677 |
7.11% |
response to antibiotic |
GO:0002793 |
7.11% |
positive regulation of peptide secretion |
GO:0062012 |
7.08% |
regulation of small molecule metabolic process |
GO:0045944 |
7.07% |
positive regulation of transcription by RNA polymerase II |
GO:0002931 |
7.05% |
response to ischemia |
GO:0007568 |
7.04% |
aging |
GO:0031667 |
7.03% |
response to nutrient levels |
GO:0002684 |
7.01% |
positive regulation of immune system process |
GO:0035176 |
7.00% |
social behavior |
GO:1903828 |
7.00% |
negative regulation of cellular protein localization |
GO:1900180 |
6.99% |
regulation of protein localization to nucleus |
GO:1900117 |
6.99% |
regulation of execution phase of apoptosis |
GO:0022414 |
6.97% |
reproductive process |
GO:0043207 |
6.96% |
response to external biotic stimulus |
GO:0071356 |
6.96% |
cellular response to tumor necrosis factor |
GO:0006954 |
6.95% |
inflammatory response |
GO:0002703 |
6.94% |
regulation of leukocyte mediated immunity |
GO:0010921 |
6.93% |
regulation of phosphatase activity |
GO:2000116 |
6.92% |
regulation of cysteine-type endopeptidase activity |
GO:0010506 |
6.92% |
regulation of autophagy |
GO:0002687 |
6.90% |
positive regulation of leukocyte migration |
GO:0060249 |
6.88% |
anatomical structure homeostasis |
GO:0032970 |
6.88% |
regulation of actin filament-based process |
GO:0032088 |
6.87% |
negative regulation of NF-kappaB transcription factor activity |
GO:0022405 |
6.86% |
hair cycle process |
GO:0010212 |
6.86% |
response to ionizing radiation |
GO:0010638 |
6.86% |
positive regulation of organelle organization |
GO:0002027 |
6.85% |
regulation of heart rate |
GO:0031646 |
6.84% |
positive regulation of nervous system process |
GO:1905269 |
6.84% |
positive regulation of chromatin organization |
GO:1904994 |
6.84% |
regulation of leukocyte adhesion to vascular endothelial cell |
GO:0050765 |
6.83% |
negative regulation of phagocytosis |
GO:0010623 |
6.83% |
programmed cell death involved in cell development |
GO:0006942 |
6.82% |
regulation of striated muscle contraction |
GO:0045995 |
6.81% |
regulation of embryonic development |
GO:1901654 |
6.80% |
response to ketone |
GO:1901342 |
6.80% |
regulation of vasculature development |
GO:0060291 |
6.80% |
long-term synaptic potentiation |
GO:0043393 |
6.79% |
regulation of protein binding |
GO:1901020 |
6.79% |
negative regulation of calcium ion transmembrane transporter activity |
GO:1901564 |
6.79% |
organonitrogen compound metabolic process |
GO:0006793 |
6.78% |
phosphorus metabolic process |
GO:0030154 |
6.78% |
cell differentiation |
GO:2001023 |
6.77% |
regulation of response to drug |
GO:0034766 |
6.76% |
negative regulation of ion transmembrane transport |
GO:1904063 |
6.76% |
negative regulation of cation transmembrane transport |
GO:1903034 |
6.75% |
regulation of response to wounding |
GO:2000677 |
6.74% |
regulation of transcription regulatory region DNA binding |
GO:0031328 |
6.74% |
positive regulation of cellular biosynthetic process |
GO:1905952 |
6.72% |
regulation of lipid localization |
GO:0055085 |
6.70% |
transmembrane transport |
GO:0051560 |
6.69% |
mitochondrial calcium ion homeostasis |
GO:0022404 |
6.68% |
molting cycle process |
GO:0007005 |
6.67% |
mitochondrion organization |
GO:0051346 |
6.67% |
negative regulation of hydrolase activity |
GO:1903018 |
6.66% |
regulation of glycoprotein metabolic process |
GO:0071407 |
6.66% |
cellular response to organic cyclic compound |
GO:1903052 |
6.65% |
positive regulation of proteolysis involved in cellular protein catabolic process |
GO:1903201 |
6.65% |
regulation of oxidative stress-induced cell death |
GO:0051093 |
6.63% |
negative regulation of developmental process |
GO:0030004 |
6.63% |
cellular monovalent inorganic cation homeostasis |
GO:0051896 |
6.61% |
regulation of protein kinase B signaling |
GO:0046777 |
6.61% |
protein autophosphorylation |
GO:0010559 |
6.61% |
regulation of glycoprotein biosynthetic process |
GO:0070588 |
6.60% |
calcium ion transmembrane transport |
GO:0051492 |
6.59% |
regulation of stress fiber assembly |
GO:0035150 |
6.59% |
regulation of tube size |
GO:2000147 |
6.57% |
positive regulation of cell motility |
GO:1901800 |
6.57% |
positive regulation of proteasomal protein catabolic process |
GO:0002262 |
6.56% |
myeloid cell homeostasis |
GO:0035296 |
6.54% |
regulation of tube diameter |
GO:0002706 |
6.52% |
regulation of lymphocyte mediated immunity |
GO:2001257 |
6.52% |
regulation of cation channel activity |
GO:0009611 |
6.51% |
response to wounding |
GO:0010976 |
6.51% |
positive regulation of neuron projection development |
GO:0055083 |
6.51% |
monovalent inorganic anion homeostasis |
GO:1900182 |
6.50% |
positive regulation of protein localization to nucleus |
GO:1903706 |
6.50% |
regulation of hemopoiesis |
GO:1902742 |
6.49% |
apoptotic process involved in development |
GO:0097305 |
6.49% |
response to alcohol |
GO:0070727 |
6.49% |
cellular macromolecule localization |
GO:0030888 |
6.48% |
regulation of B cell proliferation |
GO:0097035 |
6.48% |
regulation of membrane lipid distribution |
GO:0045913 |
6.48% |
positive regulation of carbohydrate metabolic process |
GO:1902882 |
6.48% |
regulation of response to oxidative stress |
GO:0033044 |
6.48% |
regulation of chromosome organization |
GO:0040017 |
6.47% |
positive regulation of locomotion |
GO:0009653 |
6.47% |
anatomical structure morphogenesis |
GO:0009991 |
6.46% |
response to extracellular stimulus |
GO:0032515 |
6.43% |
negative regulation of phosphoprotein phosphatase activity |
GO:0045184 |
6.42% |
establishment of protein localization |
GO:0010720 |
6.41% |
positive regulation of cell development |
GO:1901019 |
6.40% |
regulation of calcium ion transmembrane transporter activity |
GO:0008630 |
6.39% |
intrinsic apoptotic signaling pathway in response to DNA damage |
GO:0051966 |
6.39% |
regulation of synaptic transmission, glutamatergic |
GO:0031341 |
6.39% |
regulation of cell killing |
GO:0045785 |
6.39% |
positive regulation of cell adhesion |
GO:0051962 |
6.38% |
positive regulation of nervous system development |
GO:0006796 |
6.36% |
phosphate-containing compound metabolic process |
GO:0098662 |
6.34% |
inorganic cation transmembrane transport |
GO:0031343 |
6.34% |
positive regulation of cell killing |
GO:0060284 |
6.34% |
regulation of cell development |
GO:0061061 |
6.33% |
muscle structure development |
GO:0072657 |
6.33% |
protein localization to membrane |
GO:0010762 |
6.33% |
regulation of fibroblast migration |
GO:0030334 |
6.32% |
regulation of cell migration |
GO:0071705 |
6.32% |
nitrogen compound transport |
GO:0033273 |
6.31% |
response to vitamin |
GO:1902041 |
6.31% |
regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO:0001894 |
6.30% |
tissue homeostasis |
GO:0043170 |
6.30% |
macromolecule metabolic process |
GO:0071702 |
6.30% |
organic substance transport |
GO:0007009 |
6.29% |
plasma membrane organization |
GO:0050714 |
6.27% |
positive regulation of protein secretion |
GO:0018107 |
6.26% |
peptidyl-threonine phosphorylation |
GO:0051703 |
6.26% |
intraspecies interaction between organisms |
GO:0110053 |
6.22% |
regulation of actin filament organization |
GO:0090317 |
6.20% |
negative regulation of intracellular protein transport |
GO:1902807 |
6.20% |
negative regulation of cell cycle G1/S phase transition |
GO:0032368 |
6.20% |
regulation of lipid transport |
GO:0034613 |
6.19% |
cellular protein localization |
GO:0097553 |
6.19% |
calcium ion transmembrane import into cytosol |
GO:0001782 |
6.19% |
B cell homeostasis |
GO:0045930 |
6.17% |
negative regulation of mitotic cell cycle |
GO:0055088 |
6.17% |
lipid homeostasis |
GO:0030335 |
6.14% |
positive regulation of cell migration |
GO:0010906 |
6.13% |
regulation of glucose metabolic process |
GO:0036293 |
6.13% |
response to decreased oxygen levels |
GO:1903047 |
6.11% |
mitotic cell cycle process |
GO:0045670 |
6.11% |
regulation of osteoclast differentiation |
GO:0051960 |
6.10% |
regulation of nervous system development |
GO:0071364 |
6.10% |
cellular response to epidermal growth factor stimulus |
GO:0044058 |
6.07% |
regulation of digestive system process |
GO:0071674 |
6.06% |
mononuclear cell migration |
GO:0050673 |
6.06% |
epithelial cell proliferation |
GO:0070098 |
6.05% |
chemokine-mediated signaling pathway |
GO:0030198 |
6.05% |
extracellular matrix organization |
GO:0003018 |
6.05% |
vascular process in circulatory system |
GO:0032007 |
6.04% |
negative regulation of TOR signaling |
GO:0043062 |
6.04% |
extracellular structure organization |
GO:0018210 |
6.03% |
peptidyl-threonine modification |
GO:0070059 |
6.03% |
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress |
GO:0032091 |
6.02% |
negative regulation of protein binding |
GO:0032872 |
6.01% |
regulation of stress-activated MAPK cascade |
GO:0016525 |
6.01% |
negative regulation of angiogenesis |
GO:0030111 |
6.00% |
regulation of Wnt signaling pathway |
GO:0006940 |
6.00% |
regulation of smooth muscle contraction |
GO:0060135 |
5.99% |
maternal process involved in female pregnancy |
GO:0045921 |
5.99% |
positive regulation of exocytosis |
GO:1903670 |
5.96% |
regulation of sprouting angiogenesis |
GO:0032101 |
5.95% |
regulation of response to external stimulus |
GO:2000181 |
5.95% |
negative regulation of blood vessel morphogenesis |
GO:0009266 |
5.95% |
response to temperature stimulus |
GO:2000106 |
5.93% |
regulation of leukocyte apoptotic process |
GO:1903508 |
5.93% |
positive regulation of nucleic acid-templated transcription |
GO:1902680 |
5.93% |
positive regulation of RNA biosynthetic process |
GO:1901888 |
5.92% |
regulation of cell junction assembly |
GO:0001910 |
5.91% |
regulation of leukocyte mediated cytotoxicity |
GO:0098659 |
5.91% |
inorganic cation import across plasma membrane |
GO:0003012 |
5.90% |
muscle system process |
GO:0032092 |
5.89% |
positive regulation of protein binding |
GO:0001936 |
5.88% |
regulation of endothelial cell proliferation |
GO:0032006 |
5.87% |
regulation of TOR signaling |
GO:0050867 |
5.86% |
positive regulation of cell activation |
GO:0098660 |
5.85% |
inorganic ion transmembrane transport |
GO:0062013 |
5.85% |
positive regulation of small molecule metabolic process |
GO:0007346 |
5.84% |
regulation of mitotic cell cycle |
GO:0045935 |
5.84% |
positive regulation of nucleobase-containing compound metabolic process |
GO:0007584 |
5.83% |
response to nutrient |
GO:0071347 |
5.83% |
cellular response to interleukin-1 |
GO:0071363 |
5.83% |
cellular response to growth factor stimulus |
GO:0048609 |
5.82% |
multicellular organismal reproductive process |
GO:0002548 |
5.80% |
monocyte chemotaxis |
GO:0050778 |
5.80% |
positive regulation of immune response |
GO:1903364 |
5.80% |
positive regulation of cellular protein catabolic process |
GO:0001954 |
5.79% |
positive regulation of cell-matrix adhesion |
GO:0045893 |
5.79% |
positive regulation of transcription, DNA-templated |
GO:0051705 |
5.79% |
multi-organism behavior |
GO:0001938 |
5.79% |
positive regulation of endothelial cell proliferation |
GO:0009792 |
5.77% |
embryo development ending in birth or egg hatching |
GO:0070050 |
5.76% |
neuron cellular homeostasis |
GO:0051254 |
5.76% |
positive regulation of RNA metabolic process |
GO:0035308 |
5.76% |
negative regulation of protein dephosphorylation |
GO:1901988 |
5.74% |
negative regulation of cell cycle phase transition |
GO:0001919 |
5.74% |
regulation of receptor recycling |
GO:0034114 |
5.70% |
regulation of heterotypic cell-cell adhesion |
GO:0070302 |
5.70% |
regulation of stress-activated protein kinase signaling cascade |
GO:0007200 |
5.69% |
phospholipase C-activating G protein-coupled receptor signaling pathway |
GO:0062014 |
5.68% |
negative regulation of small molecule metabolic process |
GO:0010155 |
5.68% |
regulation of proton transport |
GO:0042593 |
5.68% |
glucose homeostasis |
GO:2001258 |
5.68% |
negative regulation of cation channel activity |
GO:0022409 |
5.67% |
positive regulation of cell-cell adhesion |
GO:0042110 |
5.67% |
T cell activation |
GO:0002699 |
5.67% |
positive regulation of immune effector process |
GO:0035065 |
5.67% |
regulation of histone acetylation |
GO:0022402 |
5.66% |
cell cycle process |
GO:0030100 |
5.66% |
regulation of endocytosis |
GO:0070482 |
5.66% |
response to oxygen levels |
GO:0006936 |
5.66% |
muscle contraction |
GO:0002685 |
5.64% |
regulation of leukocyte migration |
GO:1905476 |
5.64% |
negative regulation of protein localization to membrane |
GO:0001953 |
5.64% |
negative regulation of cell-matrix adhesion |
GO:0010675 |
5.63% |
regulation of cellular carbohydrate metabolic process |
GO:1903393 |
5.63% |
positive regulation of adherens junction organization |
GO:0035094 |
5.63% |
response to nicotine |
GO:0048534 |
5.63% |
hematopoietic or lymphoid organ development |
GO:1900407 |
5.62% |
regulation of cellular response to oxidative stress |
GO:2001038 |
5.62% |
regulation of cellular response to drug |
GO:0033500 |
5.61% |
carbohydrate homeostasis |
GO:1903170 |
5.60% |
negative regulation of calcium ion transmembrane transport |
GO:0046330 |
5.58% |
positive regulation of JNK cascade |
GO:2000351 |
5.58% |
regulation of endothelial cell apoptotic process |
GO:0007599 |
5.58% |
hemostasis |
GO:1903039 |
5.57% |
positive regulation of leukocyte cell-cell adhesion |
GO:0010922 |
5.55% |
positive regulation of phosphatase activity |
GO:1904035 |
5.55% |
regulation of epithelial cell apoptotic process |
GO:0043462 |
5.54% |
regulation of ATPase activity |
GO:1904037 |
5.52% |
positive regulation of epithelial cell apoptotic process |
GO:0043902 |
5.51% |
positive regulation of multi-organism process |
GO:0006997 |
5.49% |
nucleus organization |
GO:0051704 |
5.49% |
multi-organism process |
GO:0098609 |
5.48% |
cell-cell adhesion |
GO:0051590 |
5.48% |
positive regulation of neurotransmitter transport |
GO:0002700 |
5.47% |
regulation of production of molecular mediator of immune response |
GO:0099587 |
5.46% |
inorganic ion import across plasma membrane |
GO:0010557 |
5.45% |
positive regulation of macromolecule biosynthetic process |
GO:0000413 |
5.45% |
protein peptidyl-prolyl isomerization |
GO:0032496 |
5.44% |
response to lipopolysaccharide |
GO:0002697 |
5.44% |
regulation of immune effector process |
GO:2000649 |
5.43% |
regulation of sodium ion transmembrane transporter activity |
GO:0032355 |
5.42% |
response to estradiol |
GO:0033135 |
5.42% |
regulation of peptidyl-serine phosphorylation |
GO:0048285 |
5.42% |
organelle fission |
GO:0009416 |
5.42% |
response to light stimulus |
GO:1901991 |
5.39% |
negative regulation of mitotic cell cycle phase transition |
GO:1903779 |
5.38% |
regulation of cardiac conduction |
GO:0001666 |
5.38% |
response to hypoxia |
GO:0010628 |
5.37% |
positive regulation of gene expression |
GO:0010595 |
5.37% |
positive regulation of endothelial cell migration |
GO:0007275 |
5.37% |
multicellular organism development |
GO:1902305 |
5.36% |
regulation of sodium ion transmembrane transport |
GO:0051224 |
5.36% |
negative regulation of protein transport |
GO:0061041 |
5.35% |
regulation of wound healing |
GO:0000280 |
5.35% |
nuclear division |
GO:0006955 |
5.35% |
immune response |
GO:0022604 |
5.34% |
regulation of cell morphogenesis |
GO:0006468 |
5.34% |
protein phosphorylation |
GO:0045619 |
5.33% |
regulation of lymphocyte differentiation |
GO:0002819 |
5.32% |
regulation of adaptive immune response |
GO:0046486 |
5.32% |
glycerolipid metabolic process |
GO:0071375 |
5.31% |
cellular response to peptide hormone stimulus |
GO:0060193 |
5.31% |
positive regulation of lipase activity |
GO:0048232 |
5.31% |
male gamete generation |
GO:0043281 |
5.30% |
regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0051897 |
5.27% |
positive regulation of protein kinase B signaling |
GO:0007264 |
5.27% |
small GTPase mediated signal transduction |
GO:0010665 |
5.26% |
regulation of cardiac muscle cell apoptotic process |
GO:0010039 |
5.26% |
response to iron ion |
GO:0017157 |
5.26% |
regulation of exocytosis |
GO:0032376 |
5.25% |
positive regulation of cholesterol transport |
GO:0006109 |
5.25% |
regulation of carbohydrate metabolic process |
GO:0042311 |
5.25% |
vasodilation |
GO:0009895 |
5.24% |
negative regulation of catabolic process |
GO:0060401 |
5.22% |
cytosolic calcium ion transport |
GO:0060761 |
5.22% |
negative regulation of response to cytokine stimulus |
GO:0003006 |
5.21% |
developmental process involved in reproduction |
GO:0050728 |
5.21% |
negative regulation of inflammatory response |
GO:0010923 |
5.20% |
negative regulation of phosphatase activity |
GO:0070542 |
5.20% |
response to fatty acid |
GO:0051099 |
5.20% |
positive regulation of binding |
GO:0002088 |
5.19% |
lens development in camera-type eye |
GO:0045580 |
5.18% |
regulation of T cell differentiation |
GO:1904030 |
5.18% |
negative regulation of cyclin-dependent protein kinase activity |
GO:0001775 |
5.18% |
cell activation |
GO:0050878 |
5.17% |
regulation of body fluid levels |
GO:0019538 |
5.16% |
protein metabolic process |
GO:0030858 |
5.16% |
positive regulation of epithelial cell differentiation |
GO:0046328 |
5.15% |
regulation of JNK cascade |
GO:0002237 |
5.14% |
response to molecule of bacterial origin |
GO:0001942 |
5.14% |
hair follicle development |
GO:0043473 |
5.14% |
pigmentation |
GO:0070509 |
5.13% |
calcium ion import |
GO:1900046 |
5.13% |
regulation of hemostasis |
GO:0010288 |
5.12% |
response to lead ion |
GO:0048538 |
5.12% |
thymus development |
GO:0001101 |
5.10% |
response to acid chemical |
GO:0051283 |
5.10% |
negative regulation of sequestering of calcium ion |
GO:1903010 |
5.09% |
regulation of bone development |
GO:2000241 |
5.09% |
regulation of reproductive process |
GO:0034622 |
5.07% |
cellular protein-containing complex assembly |
GO:0070373 |
5.07% |
negative regulation of ERK1 and ERK2 cascade |
GO:0070661 |
5.07% |
leukocyte proliferation |
GO:1904950 |
5.07% |
negative regulation of establishment of protein localization |
GO:0032102 |
5.07% |
negative regulation of response to external stimulus |
GO:1900371 |
5.06% |
regulation of purine nucleotide biosynthetic process |
GO:0016048 |
5.06% |
detection of temperature stimulus |
GO:0031330 |
5.05% |
negative regulation of cellular catabolic process |
GO:2001244 |
5.04% |
positive regulation of intrinsic apoptotic signaling pathway |
GO:0010662 |
5.04% |
regulation of striated muscle cell apoptotic process |
GO:0007283 |
5.03% |
spermatogenesis |
GO:0010765 |
5.03% |
positive regulation of sodium ion transport |
GO:0031929 |
5.03% |
TOR signaling |
GO:1905898 |
5.03% |
positive regulation of response to endoplasmic reticulum stress |
GO:0050777 |
5.02% |
negative regulation of immune response |
GO:0010948 |
5.02% |
negative regulation of cell cycle process |
GO:0001952 |
5.02% |
regulation of cell-matrix adhesion |
GO:0050679 |
5.02% |
positive regulation of epithelial cell proliferation |
GO:1901016 |
5.01% |
regulation of potassium ion transmembrane transporter activity |
GO:0010447 |
5.01% |
response to acidic pH |
GO:0048870 |
5.00% |
cell motility |
GO:0032371 |
5.00% |
regulation of sterol transport |
GO:0007186 |
5.00% |
G protein-coupled receptor signaling pathway |
GO:1903531 |
4.99% |
negative regulation of secretion by cell |
GO:0090109 |
4.99% |
regulation of cell-substrate junction assembly |
GO:0051881 |
4.98% |
regulation of mitochondrial membrane potential |
GO:0097237 |
4.98% |
cellular response to toxic substance |
GO:1901215 |
4.97% |
negative regulation of neuron death |
GO:0007006 |
4.97% |
mitochondrial membrane organization |
GO:0034341 |
4.97% |
response to interferon-gamma |
GO:0001776 |
4.97% |
leukocyte homeostasis |
GO:0010799 |
4.96% |
regulation of peptidyl-threonine phosphorylation |
GO:0010669 |
4.96% |
epithelial structure maintenance |
GO:0010634 |
4.95% |
positive regulation of epithelial cell migration |
GO:0071346 |
4.95% |
cellular response to interferon-gamma |
GO:0032373 |
4.95% |
positive regulation of sterol transport |
GO:0050769 |
4.94% |
positive regulation of neurogenesis |
GO:0042149 |
4.94% |
cellular response to glucose starvation |
GO:0035305 |
4.94% |
negative regulation of dephosphorylation |
GO:0033628 |
4.94% |
regulation of cell adhesion mediated by integrin |
GO:0009268 |
4.93% |
response to pH |
GO:0000226 |
4.93% |
microtubule cytoskeleton organization |
GO:0045806 |
4.92% |
negative regulation of endocytosis |
GO:0071774 |
4.90% |
response to fibroblast growth factor |
GO:0030193 |
4.90% |
regulation of blood coagulation |
GO:0016477 |
4.90% |
cell migration |
GO:1901222 |
4.89% |
regulation of NIK/NF-kappaB signaling |
GO:1902903 |
4.89% |
regulation of supramolecular fiber organization |
GO:0009411 |
4.89% |
response to UV |
GO:0045664 |
4.89% |
regulation of neuron differentiation |
GO:0098739 |
4.88% |
import across plasma membrane |
GO:0098542 |
4.87% |
defense response to other organism |
GO:0046474 |
4.86% |
glycerophospholipid biosynthetic process |
GO:0051209 |
4.86% |
release of sequestered calcium ion into cytosol |
GO:0002260 |
4.86% |
lymphocyte homeostasis |
GO:0048732 |
4.86% |
gland development |
GO:0044255 |
4.86% |
cellular lipid metabolic process |
GO:0090277 |
4.86% |
positive regulation of peptide hormone secretion |
GO:0051893 |
4.86% |
regulation of focal adhesion assembly |
GO:0010821 |
4.85% |
regulation of mitochondrion organization |
GO:0009612 |
4.84% |
response to mechanical stimulus |
GO:0055067 |
4.84% |
monovalent inorganic cation homeostasis |
GO:0042060 |
4.84% |
wound healing |
GO:0002702 |
4.84% |
positive regulation of production of molecular mediator of immune response |
GO:0002009 |
4.83% |
morphogenesis of an epithelium |
GO:0072659 |
4.83% |
protein localization to plasma membrane |
GO:0010738 |
4.83% |
regulation of protein kinase A signaling |
GO:0097755 |
4.83% |
positive regulation of blood vessel diameter |
GO:0032570 |
4.82% |
response to progesterone |
GO:0015031 |
4.82% |
protein transport |
GO:0003013 |
4.81% |
circulatory system process |
GO:0043267 |
4.80% |
negative regulation of potassium ion transport |
GO:1903203 |
4.79% |
regulation of oxidative stress-induced neuron death |
GO:0051707 |
4.79% |
response to other organism |
GO:0046902 |
4.79% |
regulation of mitochondrial membrane permeability |
GO:0045666 |
4.78% |
positive regulation of neuron differentiation |
GO:2001020 |
4.77% |
regulation of response to DNA damage stimulus |
GO:0010719 |
4.77% |
negative regulation of epithelial to mesenchymal transition |
GO:0030808 |
4.77% |
regulation of nucleotide biosynthetic process |
GO:1902905 |
4.76% |
positive regulation of supramolecular fiber organization |
GO:0019217 |
4.75% |
regulation of fatty acid metabolic process |
GO:0006650 |
4.75% |
glycerophospholipid metabolic process |
GO:0016242 |
4.75% |
negative regulation of macroautophagy |
GO:0060828 |
4.74% |
regulation of canonical Wnt signaling pathway |
GO:0070301 |
4.73% |
cellular response to hydrogen peroxide |
GO:0042176 |
4.73% |
regulation of protein catabolic process |
GO:0030168 |
4.72% |
platelet activation |
GO:0050818 |
4.72% |
regulation of coagulation |
GO:1901655 |
4.72% |
cellular response to ketone |
GO:0008654 |
4.71% |
phospholipid biosynthetic process |
GO:0050773 |
4.71% |
regulation of dendrite development |
GO:0019935 |
4.71% |
cyclic-nucleotide-mediated signaling |
GO:0043268 |
4.70% |
positive regulation of potassium ion transport |
GO:2001242 |
4.69% |
regulation of intrinsic apoptotic signaling pathway |
GO:0002028 |
4.69% |
regulation of sodium ion transport |
GO:0031347 |
4.68% |
regulation of defense response |
GO:0050732 |
4.68% |
negative regulation of peptidyl-tyrosine phosphorylation |
GO:1902107 |
4.67% |
positive regulation of leukocyte differentiation |
GO:2001236 |
4.67% |
regulation of extrinsic apoptotic signaling pathway |
GO:0001960 |
4.66% |
negative regulation of cytokine-mediated signaling pathway |
GO:0002761 |
4.66% |
regulation of myeloid leukocyte differentiation |
GO:0002821 |
4.66% |
positive regulation of adaptive immune response |
GO:0007276 |
4.66% |
gamete generation |
GO:0031333 |
4.66% |
negative regulation of protein complex assembly |
GO:0045596 |
4.65% |
negative regulation of cell differentiation |
GO:0046824 |
4.64% |
positive regulation of nucleocytoplasmic transport |
GO:0032989 |
4.64% |
cellular component morphogenesis |
GO:0060402 |
4.64% |
calcium ion transport into cytosol |
GO:0048814 |
4.63% |
regulation of dendrite morphogenesis |
GO:0031175 |
4.63% |
neuron projection development |
GO:0046889 |
4.63% |
positive regulation of lipid biosynthetic process |
GO:0045017 |
4.63% |
glycerolipid biosynthetic process |
GO:0035418 |
4.63% |
protein localization to synapse |
GO:0030029 |
4.61% |
actin filament-based process |
GO:0044344 |
4.60% |
cellular response to fibroblast growth factor stimulus |
GO:0030036 |
4.60% |
actin cytoskeleton organization |
GO:0071236 |
4.60% |
cellular response to antibiotic |
GO:0040011 |
4.60% |
locomotion |
GO:0061099 |
4.57% |
negative regulation of protein tyrosine kinase activity |
GO:0050767 |
4.57% |
regulation of neurogenesis |
GO:0048729 |
4.56% |
tissue morphogenesis |
GO:0031960 |
4.56% |
response to corticosteroid |
GO:2000134 |
4.55% |
negative regulation of G1/S transition of mitotic cell cycle |
GO:0051092 |
4.54% |
positive regulation of NF-kappaB transcription factor activity |
GO:0019216 |
4.54% |
regulation of lipid metabolic process |
GO:0010812 |
4.54% |
negative regulation of cell-substrate adhesion |
GO:0034599 |
4.53% |
cellular response to oxidative stress |
GO:1990778 |
4.53% |
protein localization to cell periphery |
GO:2000758 |
4.52% |
positive regulation of peptidyl-lysine acetylation |
GO:0016050 |
4.52% |
vesicle organization |
GO:0010508 |
4.52% |
positive regulation of autophagy |
GO:0051101 |
4.52% |
regulation of DNA binding |
GO:1901343 |
4.51% |
negative regulation of vasculature development |
GO:0071277 |
4.51% |
cellular response to calcium ion |
GO:0019637 |
4.51% |
organophosphate metabolic process |
GO:0007202 |
4.50% |
activation of phospholipase C activity |
GO:1903205 |
4.50% |
regulation of hydrogen peroxide-induced cell death |
GO:0001763 |
4.50% |
morphogenesis of a branching structure |
GO:0008637 |
4.50% |
apoptotic mitochondrial changes |
GO:2000179 |
4.50% |
positive regulation of neural precursor cell proliferation |
GO:0016241 |
4.50% |
regulation of macroautophagy |
GO:0018209 |
4.50% |
peptidyl-serine modification |
GO:0010507 |
4.49% |
negative regulation of autophagy |
GO:0051602 |
4.49% |
response to electrical stimulus |
GO:0031063 |
4.48% |
regulation of histone deacetylation |
GO:0098900 |
4.48% |
regulation of action potential |
GO:0007600 |
4.46% |
sensory perception |
GO:0045732 |
4.45% |
positive regulation of protein catabolic process |
GO:0031348 |
4.45% |
negative regulation of defense response |
GO:0033137 |
4.45% |
negative regulation of peptidyl-serine phosphorylation |
GO:0051453 |
4.44% |
regulation of intracellular pH |
GO:0009056 |
4.44% |
catabolic process |
GO:0006909 |
4.44% |
phagocytosis |
GO:0051606 |
4.44% |
detection of stimulus |
GO:0030856 |
4.44% |
regulation of epithelial cell differentiation |
GO:0048010 |
4.43% |
vascular endothelial growth factor receptor signaling pathway |
GO:0034976 |
4.43% |
response to endoplasmic reticulum stress |
GO:0051607 |
4.43% |
defense response to virus |
GO:0042594 |
4.43% |
response to starvation |
GO:0070925 |
4.41% |
organelle assembly |
GO:2001024 |
4.41% |
negative regulation of response to drug |
GO:0071496 |
4.41% |
cellular response to external stimulus |
GO:0043277 |
4.41% |
apoptotic cell clearance |
GO:0034110 |
4.41% |
regulation of homotypic cell-cell adhesion |
GO:0071398 |
4.40% |
cellular response to fatty acid |
GO:0071216 |
4.40% |
cellular response to biotic stimulus |
GO:1901985 |
4.40% |
positive regulation of protein acetylation |
GO:0050727 |
4.39% |
regulation of inflammatory response |
GO:0010863 |
4.39% |
positive regulation of phospholipase C activity |
GO:0090407 |
4.38% |
organophosphate biosynthetic process |
GO:0048468 |
4.37% |
cell development |
GO:0032374 |
4.37% |
regulation of cholesterol transport |
GO:1904029 |
4.37% |
regulation of cyclin-dependent protein kinase activity |
GO:0051271 |
4.36% |
negative regulation of cellular component movement |
GO:0071470 |
4.36% |
cellular response to osmotic stress |
GO:0048041 |
4.36% |
focal adhesion assembly |
GO:1903307 |
4.35% |
positive regulation of regulated secretory pathway |
GO:0060070 |
4.34% |
canonical Wnt signaling pathway |
GO:2000171 |
4.34% |
negative regulation of dendrite development |
GO:0015833 |
4.33% |
peptide transport |
GO:0090066 |
4.33% |
regulation of anatomical structure size |
GO:0051302 |
4.32% |
regulation of cell division |
GO:0007268 |
4.32% |
chemical synaptic transmission |
GO:0043491 |
4.32% |
protein kinase B signaling |
GO:0002696 |
4.31% |
positive regulation of leukocyte activation |
GO:0009743 |
4.31% |
response to carbohydrate |
GO:0050873 |
4.31% |
brown fat cell differentiation |
GO:0032869 |
4.31% |
cellular response to insulin stimulus |
GO:0032436 |
4.30% |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO:0038179 |
4.30% |
neurotrophin signaling pathway |
GO:0044267 |
4.30% |
cellular protein metabolic process |
GO:0046649 |
4.28% |
lymphocyte activation |
GO:0009887 |
4.28% |
animal organ morphogenesis |
GO:0009408 |
4.27% |
response to heat |
GO:0030195 |
4.27% |
negative regulation of blood coagulation |
GO:0043255 |
4.27% |
regulation of carbohydrate biosynthetic process |
GO:0002705 |
4.27% |
positive regulation of leukocyte mediated immunity |
GO:0051384 |
4.27% |
response to glucocorticoid |
GO:0009790 |
4.26% |
embryo development |
GO:0070229 |
4.26% |
negative regulation of lymphocyte apoptotic process |
GO:0040013 |
4.26% |
negative regulation of locomotion |
GO:0006906 |
4.26% |
vesicle fusion |
GO:0032874 |
4.25% |
positive regulation of stress-activated MAPK cascade |
GO:0051048 |
4.25% |
negative regulation of secretion |
GO:0061178 |
4.24% |
regulation of insulin secretion involved in cellular response to glucose stimulus |
GO:0098916 |
4.23% |
anterograde trans-synaptic signaling |
GO:0071383 |
4.23% |
cellular response to steroid hormone stimulus |
GO:0008286 |
4.22% |
insulin receptor signaling pathway |
GO:0006140 |
4.21% |
regulation of nucleotide metabolic process |
GO:0035774 |
4.21% |
positive regulation of insulin secretion involved in cellular response to glucose stimulus |
GO:2000146 |
4.21% |
negative regulation of cell motility |
GO:0061138 |
4.21% |
morphogenesis of a branching epithelium |
GO:0022406 |
4.21% |
membrane docking |
GO:1905330 |
4.19% |
regulation of morphogenesis of an epithelium |
GO:0043536 |
4.19% |
positive regulation of blood vessel endothelial cell migration |
GO:0016310 |
4.18% |
phosphorylation |
GO:0050817 |
4.18% |
coagulation |
GO:0070570 |
4.18% |
regulation of neuron projection regeneration |
GO:0006629 |
4.18% |
lipid metabolic process |
GO:1900120 |
4.17% |
regulation of receptor binding |
GO:0032868 |
4.16% |
response to insulin |
GO:0007045 |
4.16% |
cell-substrate adherens junction assembly |
GO:0031349 |
4.16% |
positive regulation of defense response |
GO:0046825 |
4.16% |
regulation of protein export from nucleus |
GO:1902883 |
4.14% |
negative regulation of response to oxidative stress |
GO:0090330 |
4.13% |
regulation of platelet aggregation |
GO:0010769 |
4.13% |
regulation of cell morphogenesis involved in differentiation |
GO:0032469 |
4.13% |
endoplasmic reticulum calcium ion homeostasis |
GO:0010656 |
4.12% |
negative regulation of muscle cell apoptotic process |
GO:0046822 |
4.11% |
regulation of nucleocytoplasmic transport |
GO:0031954 |
4.11% |
positive regulation of protein autophosphorylation |
GO:0006644 |
4.11% |
phospholipid metabolic process |
GO:0071901 |
4.10% |
negative regulation of protein serine/threonine kinase activity |
GO:0043534 |
4.10% |
blood vessel endothelial cell migration |
GO:0040008 |
4.10% |
regulation of growth |
GO:1901987 |
4.10% |
regulation of cell cycle phase transition |
GO:2000108 |
4.09% |
positive regulation of leukocyte apoptotic process |
GO:0031346 |
4.08% |
positive regulation of cell projection organization |
GO:0014904 |
4.07% |
myotube cell development |
GO:0071902 |
4.07% |
positive regulation of protein serine/threonine kinase activity |
GO:1902806 |
4.07% |
regulation of cell cycle G1/S phase transition |
GO:1903391 |
4.07% |
regulation of adherens junction organization |
GO:0042886 |
4.06% |
amide transport |
GO:0030178 |
4.06% |
negative regulation of Wnt signaling pathway |
GO:1900047 |
4.06% |
negative regulation of hemostasis |
GO:1903321 |
4.06% |
negative regulation of protein modification by small protein conjugation or removal |
GO:0043502 |
4.06% |
regulation of muscle adaptation |
GO:0002718 |
4.05% |
regulation of cytokine production involved in immune response |
GO:0046883 |
4.04% |
regulation of hormone secretion |
GO:0006111 |
4.04% |
regulation of gluconeogenesis |
GO:0045321 |
4.04% |
leukocyte activation |
GO:1901184 |
4.04% |
regulation of ERBB signaling pathway |
GO:0061025 |
4.03% |
membrane fusion |
GO:0045471 |
4.03% |
response to ethanol |
GO:0045637 |
4.02% |
regulation of myeloid cell differentiation |
GO:0035690 |
4.02% |
cellular response to drug |
GO:0043434 |
4.01% |
response to peptide hormone |
GO:0007389 |
4.01% |
pattern specification process |
GO:0046903 |
4.01% |
secretion |
GO:0009581 |
4.01% |
detection of external stimulus |
GO:0007266 |
4.01% |
Rho protein signal transduction |
GO:0040007 |
4.01% |
growth |
GO:0050680 |
4.01% |
negative regulation of epithelial cell proliferation |
GO:0035023 |
4.01% |
regulation of Rho protein signal transduction |
GO:0001819 |
4.00% |
positive regulation of cytokine production |
GO:0035567 |
4.00% |
non-canonical Wnt signaling pathway |
GO:0097421 |
4.00% |
liver regeneration |
GO:0071322 |
4.00% |
cellular response to carbohydrate stimulus |
GO:1901990 |
3.99% |
regulation of mitotic cell cycle phase transition |
GO:0042098 |
3.99% |
T cell proliferation |
GO:0048511 |
3.99% |
rhythmic process |
GO:0090311 |
3.98% |
regulation of protein deacetylation |
GO:0043200 |
3.98% |
response to amino acid |
GO:0090559 |
3.97% |
regulation of membrane permeability |
GO:0090199 |
3.97% |
regulation of release of cytochrome c from mitochondria |
GO:0002831 |
3.97% |
regulation of response to biotic stimulus |
GO:0043412 |
3.97% |
macromolecule modification |
GO:0032956 |
3.97% |
regulation of actin cytoskeleton organization |
GO:0051452 |
3.96% |
intracellular pH reduction |
GO:0030099 |
3.96% |
myeloid cell differentiation |
GO:0030182 |
3.95% |
neuron differentiation |
GO:0010565 |
3.95% |
regulation of cellular ketone metabolic process |
GO:0030641 |
3.94% |
regulation of cellular pH |
GO:0099536 |
3.93% |
synaptic signaling |
GO:0007215 |
3.93% |
glutamate receptor signaling pathway |
GO:0048771 |
3.92% |
tissue remodeling |
GO:0044260 |
3.92% |
cellular macromolecule metabolic process |
GO:0007265 |
3.92% |
Ras protein signal transduction |
GO:0050850 |
3.92% |
positive regulation of calcium-mediated signaling |
GO:0045185 |
3.90% |
maintenance of protein location |
GO:0035914 |
3.89% |
skeletal muscle cell differentiation |
GO:0098657 |
3.89% |
import into cell |
GO:1903050 |
3.88% |
regulation of proteolysis involved in cellular protein catabolic process |
GO:0010664 |
3.88% |
negative regulation of striated muscle cell apoptotic process |
GO:0006879 |
3.88% |
cellular iron ion homeostasis |
GO:0019933 |
3.88% |
cAMP-mediated signaling |
GO:0070304 |
3.87% |
positive regulation of stress-activated protein kinase signaling cascade |
GO:0045933 |
3.87% |
positive regulation of muscle contraction |
GO:1903362 |
3.87% |
regulation of cellular protein catabolic process |
GO:0030336 |
3.87% |
negative regulation of cell migration |
GO:0050764 |
3.86% |
regulation of phagocytosis |
GO:0071229 |
3.85% |
cellular response to acid chemical |
GO:0051056 |
3.85% |
regulation of small GTPase mediated signal transduction |
GO:1903707 |
3.85% |
negative regulation of hemopoiesis |
GO:1903747 |
3.85% |
regulation of establishment of protein localization to mitochondrion |
GO:0001935 |
3.85% |
endothelial cell proliferation |
GO:0043900 |
3.85% |
regulation of multi-organism process |
GO:0006323 |
3.84% |
DNA packaging |
GO:0007596 |
3.84% |
blood coagulation |
GO:0033081 |
3.84% |
regulation of T cell differentiation in thymus |
GO:0010717 |
3.83% |
regulation of epithelial to mesenchymal transition |
GO:0043392 |
3.83% |
negative regulation of DNA binding |
GO:0005979 |
3.82% |
regulation of glycogen biosynthetic process |
GO:0043524 |
3.82% |
negative regulation of neuron apoptotic process |
GO:0006376 |
3.82% |
mRNA splice site selection |
GO:0042058 |
3.81% |
regulation of epidermal growth factor receptor signaling pathway |
GO:2000060 |
3.81% |
positive regulation of ubiquitin-dependent protein catabolic process |
GO:0021766 |
3.81% |
hippocampus development |
GO:0002791 |
3.80% |
regulation of peptide secretion |
GO:0009617 |
3.79% |
response to bacterium |
GO:0030261 |
3.79% |
chromosome condensation |
GO:0032103 |
3.79% |
positive regulation of response to external stimulus |
GO:0009888 |
3.79% |
tissue development |
GO:0048679 |
3.78% |
regulation of axon regeneration |
GO:0034122 |
3.78% |
negative regulation of toll-like receptor signaling pathway |
GO:0099601 |
3.78% |
regulation of neurotransmitter receptor activity |
GO:1900542 |
3.78% |
regulation of purine nucleotide metabolic process |
GO:0031100 |
3.78% |
animal organ regeneration |
GO:0043405 |
3.77% |
regulation of MAP kinase activity |
GO:1901224 |
3.77% |
positive regulation of NIK/NF-kappaB signaling |
GO:0010165 |
3.77% |
response to X-ray |
GO:0010660 |
3.77% |
regulation of muscle cell apoptotic process |
GO:0030968 |
3.77% |
endoplasmic reticulum unfolded protein response |
GO:0044248 |
3.76% |
cellular catabolic process |
GO:1904376 |
3.76% |
negative regulation of protein localization to cell periphery |
GO:0000278 |
3.76% |
mitotic cell cycle |
GO:0030900 |
3.76% |
forebrain development |
GO:0007423 |
3.76% |
sensory organ development |
GO:0043279 |
3.75% |
response to alkaloid |
GO:0045851 |
3.75% |
pH reduction |
GO:0006813 |
3.75% |
potassium ion transport |
GO:0002709 |
3.75% |
regulation of T cell mediated immunity |
GO:0010543 |
3.74% |
regulation of platelet activation |
GO:2001234 |
3.74% |
negative regulation of apoptotic signaling pathway |
GO:0014013 |
3.74% |
regulation of gliogenesis |
GO:0046890 |
3.74% |
regulation of lipid biosynthetic process |
GO:0050819 |
3.73% |
negative regulation of coagulation |
GO:1900273 |
3.72% |
positive regulation of long-term synaptic potentiation |
GO:0010667 |
3.72% |
negative regulation of cardiac muscle cell apoptotic process |
GO:0002704 |
3.71% |
negative regulation of leukocyte mediated immunity |
GO:0018193 |
3.71% |
peptidyl-amino acid modification |
GO:1905332 |
3.71% |
positive regulation of morphogenesis of an epithelium |
GO:0002698 |
3.71% |
negative regulation of immune effector process |
GO:0009582 |
3.71% |
detection of abiotic stimulus |
GO:0090288 |
3.70% |
negative regulation of cellular response to growth factor stimulus |
GO:1903035 |
3.70% |
negative regulation of response to wounding |
GO:0032024 |
3.69% |
positive regulation of insulin secretion |
GO:0043535 |
3.69% |
regulation of blood vessel endothelial cell migration |
GO:2000772 |
3.69% |
regulation of cellular senescence |
GO:1903036 |
3.68% |
positive regulation of response to wounding |
GO:0048598 |
3.67% |
embryonic morphogenesis |
GO:0035066 |
3.67% |
positive regulation of histone acetylation |
GO:0006457 |
3.66% |
protein folding |
GO:1901031 |
3.66% |
regulation of response to reactive oxygen species |
GO:0016192 |
3.65% |
vesicle-mediated transport |
GO:1904018 |
3.65% |
positive regulation of vasculature development |
GO:0001764 |
3.64% |
neuron migration |
GO:0036211 |
3.64% |
protein modification process |
GO:0051153 |
3.64% |
regulation of striated muscle cell differentiation |
GO:0002707 |
3.64% |
negative regulation of lymphocyte mediated immunity |
GO:0006325 |
3.64% |
chromatin organization |
GO:0032677 |
3.63% |
regulation of interleukin-8 production |
GO:0045926 |
3.63% |
negative regulation of growth |
GO:0032925 |
3.62% |
regulation of activin receptor signaling pathway |
GO:0034105 |
3.62% |
positive regulation of tissue remodeling |
GO:0032757 |
3.61% |
positive regulation of interleukin-8 production |
GO:0051569 |
3.61% |
regulation of histone H3-K4 methylation |
GO:0031065 |
3.60% |
positive regulation of histone deacetylation |
GO:0072331 |
3.60% |
signal transduction by p53 class mediator |
GO:0034614 |
3.58% |
cellular response to reactive oxygen species |
GO:0060456 |
3.58% |
positive regulation of digestive system process |
GO:0060393 |
3.58% |
regulation of pathway-restricted SMAD protein phosphorylation |
GO:0010810 |
3.58% |
regulation of cell-substrate adhesion |
GO:0048678 |
3.58% |
response to axon injury |
GO:0030316 |
3.57% |
osteoclast differentiation |
GO:0061045 |
3.57% |
negative regulation of wound healing |
GO:0061217 |
3.57% |
regulation of mesonephros development |
GO:0006939 |
3.56% |
smooth muscle contraction |
GO:0001501 |
3.56% |
skeletal system development |
GO:2000177 |
3.56% |
regulation of neural precursor cell proliferation |
GO:0007188 |
3.55% |
adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
GO:2000107 |
3.55% |
negative regulation of leukocyte apoptotic process |
GO:0051493 |
3.55% |
regulation of cytoskeleton organization |
GO:0071478 |
3.55% |
cellular response to radiation |
GO:0017148 |
3.54% |
negative regulation of translation |
GO:0006464 |
3.54% |
cellular protein modification process |
GO:0051052 |
3.54% |
regulation of DNA metabolic process |
GO:0045444 |
3.54% |
fat cell differentiation |
GO:0060606 |
3.54% |
tube closure |
GO:0060143 |
3.53% |
positive regulation of syncytium formation by plasma membrane fusion |
GO:0035239 |
3.53% |
tube morphogenesis |
GO:0070527 |
3.53% |
platelet aggregation |
GO:0051930 |
3.52% |
regulation of sensory perception of pain |
GO:0048608 |
3.52% |
reproductive structure development |
GO:0034284 |
3.52% |
response to monosaccharide |
GO:0043543 |
3.51% |
protein acylation |
GO:0048589 |
3.51% |
developmental growth |
GO:1903672 |
3.50% |
positive regulation of sprouting angiogenesis |
GO:0070371 |
3.50% |
ERK1 and ERK2 cascade |
GO:0015748 |
3.50% |
organophosphate ester transport |
GO:0007229 |
3.50% |
integrin-mediated signaling pathway |
GO:0006959 |
3.50% |
humoral immune response |
GO:0099537 |
3.50% |
trans-synaptic signaling |
GO:0090183 |
3.50% |
regulation of kidney development |
GO:0051968 |
3.48% |
positive regulation of synaptic transmission, glutamatergic |
GO:0051588 |
3.48% |
regulation of neurotransmitter transport |
GO:1903555 |
3.48% |
regulation of tumor necrosis factor superfamily cytokine production |
GO:0010518 |
3.48% |
positive regulation of phospholipase activity |
GO:1901385 |
3.46% |
regulation of voltage-gated calcium channel activity |
GO:0002763 |
3.45% |
positive regulation of myeloid leukocyte differentiation |
GO:0050708 |
3.45% |
regulation of protein secretion |
GO:0046578 |
3.45% |
regulation of Ras protein signal transduction |
GO:0090174 |
3.45% |
organelle membrane fusion |
GO:0070920 |
3.45% |
regulation of production of small RNA involved in gene silencing by RNA |
GO:0010823 |
3.44% |
negative regulation of mitochondrion organization |
GO:0007413 |
3.44% |
axonal fasciculation |
GO:0071695 |
3.44% |
anatomical structure maturation |
GO:0043248 |
3.44% |
proteasome assembly |
GO:0051262 |
3.44% |
protein tetramerization |
GO:0000079 |
3.43% |
regulation of cyclin-dependent protein serine/threonine kinase activity |
GO:0007187 |
3.43% |
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0009058 |
3.42% |
biosynthetic process |
GO:0043112 |
3.42% |
receptor metabolic process |
GO:0051054 |
3.41% |
positive regulation of DNA metabolic process |
GO:0014074 |
3.41% |
response to purine-containing compound |
GO:0034109 |
3.41% |
homotypic cell-cell adhesion |
GO:0034103 |
3.41% |
regulation of tissue remodeling |
GO:0007044 |
3.40% |
cell-substrate junction assembly |
GO:0110020 |
3.40% |
regulation of actomyosin structure organization |
GO:0001678 |
3.40% |
cellular glucose homeostasis |
GO:0010977 |
3.40% |
negative regulation of neuron projection development |
GO:0055072 |
3.40% |
iron ion homeostasis |
GO:0060142 |
3.39% |
regulation of syncytium formation by plasma membrane fusion |
GO:0010817 |
3.38% |
regulation of hormone levels |
GO:0060998 |
3.38% |
regulation of dendritic spine development |
GO:1900181 |
3.38% |
negative regulation of protein localization to nucleus |
GO:1901575 |
3.37% |
organic substance catabolic process |
GO:0048741 |
3.37% |
skeletal muscle fiber development |
GO:0051147 |
3.36% |
regulation of muscle cell differentiation |
GO:0106030 |
3.36% |
neuron projection fasciculation |
GO:1903798 |
3.36% |
regulation of production of miRNAs involved in gene silencing by miRNA |
GO:0010712 |
3.36% |
regulation of collagen metabolic process |
GO:0032680 |
3.36% |
regulation of tumor necrosis factor production |
GO:0015850 |
3.34% |
organic hydroxy compound transport |
GO:0034695 |
3.34% |
response to prostaglandin E |
GO:0051251 |
3.34% |
positive regulation of lymphocyte activation |
GO:0046888 |
3.34% |
negative regulation of hormone secretion |
GO:0000902 |
3.33% |
cell morphogenesis |
GO:0008340 |
3.33% |
determination of adult lifespan |
GO:0071260 |
3.33% |
cellular response to mechanical stimulus |
GO:2001252 |
3.33% |
positive regulation of chromosome organization |
GO:0033138 |
3.33% |
positive regulation of peptidyl-serine phosphorylation |
GO:0007189 |
3.32% |
adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO:0051604 |
3.32% |
protein maturation |
GO:0010470 |
3.32% |
regulation of gastrulation |
GO:0001885 |
3.31% |
endothelial cell development |
GO:0043029 |
3.30% |
T cell homeostasis |
GO:1902622 |
3.30% |
regulation of neutrophil migration |
GO:0043542 |
3.30% |
endothelial cell migration |
GO:0009615 |
3.29% |
response to virus |
GO:1903202 |
3.29% |
negative regulation of oxidative stress-induced cell death |
GO:0010469 |
3.29% |
regulation of signaling receptor activity |
GO:0002250 |
3.28% |
adaptive immune response |
GO:0051495 |
3.28% |
positive regulation of cytoskeleton organization |
GO:0031000 |
3.28% |
response to caffeine |
GO:0042476 |
3.28% |
odontogenesis |
GO:1902624 |
3.27% |
positive regulation of neutrophil migration |
GO:0009749 |
3.27% |
response to glucose |
GO:0080154 |
3.27% |
regulation of fertilization |
GO:0050954 |
3.27% |
sensory perception of mechanical stimulus |
GO:1900408 |
3.26% |
negative regulation of cellular response to oxidative stress |
GO:0006473 |
3.26% |
protein acetylation |
GO:0002715 |
3.26% |
regulation of natural killer cell mediated immunity |
GO:0043009 |
3.25% |
chordate embryonic development |
GO:0045581 |
3.25% |
negative regulation of T cell differentiation |
GO:0010771 |
3.25% |
negative regulation of cell morphogenesis involved in differentiation |
GO:0042771 |
3.24% |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
GO:0051235 |
3.24% |
maintenance of location |
GO:0010951 |
3.24% |
negative regulation of endopeptidase activity |
GO:0009746 |
3.23% |
response to hexose |
GO:0001508 |
3.21% |
action potential |
GO:0090263 |
3.21% |
positive regulation of canonical Wnt signaling pathway |
GO:0007015 |
3.20% |
actin filament organization |
GO:0071479 |
3.20% |
cellular response to ionizing radiation |
GO:0006984 |
3.20% |
ER-nucleus signaling pathway |
GO:0035904 |
3.20% |
aorta development |
GO:0030308 |
3.20% |
negative regulation of cell growth |
GO:0045761 |
3.19% |
regulation of adenylate cyclase activity |
GO:0043406 |
3.19% |
positive regulation of MAP kinase activity |
GO:0032465 |
3.19% |
regulation of cytokinesis |
GO:0006883 |
3.19% |
cellular sodium ion homeostasis |
GO:0022412 |
3.18% |
cellular process involved in reproduction in multicellular organism |
GO:0050982 |
3.18% |
detection of mechanical stimulus |
GO:0048754 |
3.18% |
branching morphogenesis of an epithelial tube |
GO:0060537 |
3.18% |
muscle tissue development |
GO:0048168 |
3.17% |
regulation of neuronal synaptic plasticity |
GO:0021987 |
3.17% |
cerebral cortex development |
GO:0009267 |
3.17% |
cellular response to starvation |
GO:0010608 |
3.16% |
posttranscriptional regulation of gene expression |
GO:0051931 |
3.16% |
regulation of sensory perception |
GO:0018208 |
3.16% |
peptidyl-proline modification |
GO:2000114 |
3.15% |
regulation of establishment of cell polarity |
GO:0045987 |
3.15% |
positive regulation of smooth muscle contraction |
GO:0045980 |
3.15% |
negative regulation of nucleotide metabolic process |
GO:0071385 |
3.15% |
cellular response to glucocorticoid stimulus |
GO:0045787 |
3.14% |
positive regulation of cell cycle |
GO:0140013 |
3.14% |
meiotic nuclear division |
GO:0050808 |
3.14% |
synapse organization |
GO:1901576 |
3.13% |
organic substance biosynthetic process |
GO:0007178 |
3.13% |
transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0050974 |
3.13% |
detection of mechanical stimulus involved in sensory perception |
GO:2000679 |
3.13% |
positive regulation of transcription regulatory region DNA binding |
GO:0003254 |
3.13% |
regulation of membrane depolarization |
GO:0043467 |
3.12% |
regulation of generation of precursor metabolites and energy |
GO:0071468 |
3.12% |
cellular response to acidic pH |
GO:0045453 |
3.12% |
bone resorption |
GO:1903426 |
3.12% |
regulation of reactive oxygen species biosynthetic process |
GO:0006869 |
3.11% |
lipid transport |
GO:0090303 |
3.11% |
positive regulation of wound healing |
GO:0034644 |
3.10% |
cellular response to UV |
GO:0031397 |
3.10% |
negative regulation of protein ubiquitination |
GO:0031342 |
3.09% |
negative regulation of cell killing |
GO:0046907 |
3.09% |
intracellular transport |
GO:0042269 |
3.09% |
regulation of natural killer cell mediated cytotoxicity |
GO:0006928 |
3.09% |
movement of cell or subcellular component |
GO:0014066 |
3.09% |
regulation of phosphatidylinositol 3-kinase signaling |
GO:0033365 |
3.08% |
protein localization to organelle |
GO:0010830 |
3.08% |
regulation of myotube differentiation |
GO:0006935 |
3.08% |
chemotaxis |
GO:1902235 |
3.08% |
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway |
GO:2000027 |
3.08% |
regulation of animal organ morphogenesis |
GO:0031057 |
3.08% |
negative regulation of histone modification |
GO:0042026 |
3.07% |
protein refolding |
GO:0006661 |
3.07% |
phosphatidylinositol biosynthetic process |
GO:0045620 |
3.07% |
negative regulation of lymphocyte differentiation |
GO:1901380 |
3.06% |
negative regulation of potassium ion transmembrane transport |
GO:0050871 |
3.06% |
positive regulation of B cell activation |
GO:0045582 |
3.06% |
positive regulation of T cell differentiation |
GO:0031669 |
3.06% |
cellular response to nutrient levels |
GO:0042307 |
3.05% |
positive regulation of protein import into nucleus |
GO:0042770 |
3.05% |
signal transduction in response to DNA damage |
GO:1903305 |
3.05% |
regulation of regulated secretory pathway |
GO:0000165 |
3.04% |
MAPK cascade |
GO:0050771 |
3.03% |
negative regulation of axonogenesis |
GO:0045834 |
3.03% |
positive regulation of lipid metabolic process |
GO:2000377 |
3.03% |
regulation of reactive oxygen species metabolic process |
GO:0051640 |
3.03% |
organelle localization |
GO:0070303 |
3.03% |
negative regulation of stress-activated protein kinase signaling cascade |
GO:0031069 |
3.03% |
hair follicle morphogenesis |
GO:0045088 |
3.03% |
regulation of innate immune response |
GO:0045766 |
3.02% |
positive regulation of angiogenesis |
GO:0014015 |
3.02% |
positive regulation of gliogenesis |
GO:1902175 |
3.02% |
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway |
GO:0033555 |
3.02% |
multicellular organismal response to stress |
GO:0036294 |
3.02% |
cellular response to decreased oxygen levels |
GO:1905268 |
3.02% |
negative regulation of chromatin organization |
GO:0061136 |
3.02% |
regulation of proteasomal protein catabolic process |
GO:0002833 |
3.01% |
positive regulation of response to biotic stimulus |
GO:0002822 |
3.01% |
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:2000117 |
3.01% |
negative regulation of cysteine-type endopeptidase activity |
GO:0010962 |
3.00% |
regulation of glucan biosynthetic process |
GO:0006885 |
3.00% |
regulation of pH |
GO:0010466 |
2.99% |
negative regulation of peptidase activity |
GO:0044249 |
2.99% |
cellular biosynthetic process |
GO:0120163 |
2.99% |
negative regulation of cold-induced thermogenesis |
GO:0071331 |
2.98% |
cellular response to hexose stimulus |
GO:0031060 |
2.98% |
regulation of histone methylation |
GO:1900024 |
2.98% |
regulation of substrate adhesion-dependent cell spreading |
GO:0032890 |
2.98% |
regulation of organic acid transport |
GO:0016485 |
2.98% |
protein processing |
GO:0045577 |
2.97% |
regulation of B cell differentiation |
GO:1903306 |
2.97% |
negative regulation of regulated secretory pathway |
GO:0015914 |
2.96% |
phospholipid transport |
GO:0007029 |
2.96% |
endoplasmic reticulum organization |
GO:0010800 |
2.96% |
positive regulation of peptidyl-threonine phosphorylation |
GO:1901566 |
2.95% |
organonitrogen compound biosynthetic process |
GO:0043506 |
2.95% |
regulation of JUN kinase activity |
GO:0071467 |
2.95% |
cellular response to pH |
GO:0010883 |
2.95% |
regulation of lipid storage |
GO:0090207 |
2.95% |
regulation of triglyceride metabolic process |
GO:0001568 |
2.94% |
blood vessel development |
GO:0051701 |
2.94% |
interaction with host |
GO:0046850 |
2.94% |
regulation of bone remodeling |
GO:0032873 |
2.93% |
negative regulation of stress-activated MAPK cascade |
GO:0034121 |
2.93% |
regulation of toll-like receptor signaling pathway |
GO:0031668 |
2.93% |
cellular response to extracellular stimulus |
GO:0010611 |
2.92% |
regulation of cardiac muscle hypertrophy |
GO:0050900 |
2.92% |
leukocyte migration |
GO:0042177 |
2.91% |
negative regulation of protein catabolic process |
GO:0002708 |
2.91% |
positive regulation of lymphocyte mediated immunity |
GO:0071312 |
2.90% |
cellular response to alkaloid |
GO:0048284 |
2.90% |
organelle fusion |
GO:0007420 |
2.90% |
brain development |
GO:1902106 |
2.90% |
negative regulation of leukocyte differentiation |
GO:0006417 |
2.89% |
regulation of translation |
GO:0071219 |
2.89% |
cellular response to molecule of bacterial origin |
GO:1903708 |
2.88% |
positive regulation of hemopoiesis |
GO:0048747 |
2.88% |
muscle fiber development |
GO:0071326 |
2.88% |
cellular response to monosaccharide stimulus |
GO:2001259 |
2.87% |
positive regulation of cation channel activity |
GO:0090287 |
2.87% |
regulation of cellular response to growth factor stimulus |
GO:0031099 |
2.87% |
regeneration |
GO:0034446 |
2.86% |
substrate adhesion-dependent cell spreading |
GO:0030177 |
2.86% |
positive regulation of Wnt signaling pathway |
GO:2001039 |
2.86% |
negative regulation of cellular response to drug |
GO:0045682 |
2.86% |
regulation of epidermis development |
GO:0071453 |
2.86% |
cellular response to oxygen levels |
GO:0001701 |
2.86% |
in utero embryonic development |
GO:0010811 |
2.85% |
positive regulation of cell-substrate adhesion |
GO:0043627 |
2.85% |
response to estrogen |
GO:0042475 |
2.85% |
odontogenesis of dentin-containing tooth |
GO:0001662 |
2.85% |
behavioral fear response |
GO:0110110 |
2.85% |
positive regulation of animal organ morphogenesis |
GO:0051301 |
2.84% |
cell division |
GO:0034250 |
2.84% |
positive regulation of cellular amide metabolic process |
GO:0071168 |
2.84% |
protein localization to chromatin |
GO:1903557 |
2.84% |
positive regulation of tumor necrosis factor superfamily cytokine production |
GO:1904036 |
2.84% |
negative regulation of epithelial cell apoptotic process |
GO:0022602 |
2.84% |
ovulation cycle process |
GO:0021700 |
2.83% |
developmental maturation |
GO:0071621 |
2.82% |
granulocyte chemotaxis |
GO:0046847 |
2.82% |
filopodium assembly |
GO:0036270 |
2.81% |
response to diuretic |
GO:0071333 |
2.81% |
cellular response to glucose stimulus |
GO:0090304 |
2.81% |
nucleic acid metabolic process |
GO:0099072 |
2.81% |
regulation of postsynaptic membrane neurotransmitter receptor levels |
GO:0050709 |
2.81% |
negative regulation of protein secretion |
GO:0045454 |
2.80% |
cell redox homeostasis |
GO:0034694 |
2.80% |
response to prostaglandin |
GO:1901984 |
2.80% |
negative regulation of protein acetylation |
GO:2000045 |
2.80% |
regulation of G1/S transition of mitotic cell cycle |
GO:2001022 |
2.80% |
positive regulation of response to DNA damage stimulus |
GO:0050921 |
2.79% |
positive regulation of chemotaxis |
GO:0001570 |
2.79% |
vasculogenesis |
GO:0023014 |
2.79% |
signal transduction by protein phosphorylation |
GO:0050729 |
2.79% |
positive regulation of inflammatory response |
GO:0090101 |
2.79% |
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0008610 |
2.78% |
lipid biosynthetic process |
GO:0071320 |
2.78% |
cellular response to cAMP |
GO:0031279 |
2.78% |
regulation of cyclase activity |
GO:0002252 |
2.78% |
immune effector process |
GO:0032692 |
2.78% |
negative regulation of interleukin-1 production |
GO:0055001 |
2.77% |
muscle cell development |
GO:0060326 |
2.77% |
cell chemotaxis |
GO:0060191 |
2.77% |
regulation of lipase activity |
GO:0090342 |
2.77% |
regulation of cell aging |
GO:0032733 |
2.76% |
positive regulation of interleukin-10 production |
GO:0090092 |
2.76% |
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0032760 |
2.75% |
positive regulation of tumor necrosis factor production |
GO:0043624 |
2.75% |
cellular protein complex disassembly |
GO:0032675 |
2.75% |
regulation of interleukin-6 production |
GO:0097327 |
2.75% |
response to antineoplastic agent |
GO:0090090 |
2.74% |
negative regulation of canonical Wnt signaling pathway |
GO:0043372 |
2.74% |
positive regulation of CD4-positive, alpha-beta T cell differentiation |
GO:0043154 |
2.74% |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0071825 |
2.73% |
protein-lipid complex subunit organization |
GO:0045742 |
2.73% |
positive regulation of epidermal growth factor receptor signaling pathway |
GO:2001021 |
2.73% |
negative regulation of response to DNA damage stimulus |
GO:0030593 |
2.73% |
neutrophil chemotaxis |
GO:0048864 |
2.73% |
stem cell development |
GO:0071230 |
2.73% |
cellular response to amino acid stimulus |
GO:0140056 |
2.72% |
organelle localization by membrane tethering |
GO:0035335 |
2.72% |
peptidyl-tyrosine dephosphorylation |
GO:0071103 |
2.70% |
DNA conformation change |
GO:0045920 |
2.70% |
negative regulation of exocytosis |
GO:0090276 |
2.70% |
regulation of peptide hormone secretion |
GO:1904589 |
2.70% |
regulation of protein import |
GO:0006396 |
2.70% |
RNA processing |
GO:1900274 |
2.70% |
regulation of phospholipase C activity |
GO:0045672 |
2.70% |
positive regulation of osteoclast differentiation |
GO:0010831 |
2.69% |
positive regulation of myotube differentiation |
GO:0042330 |
2.68% |
taxis |
GO:0071456 |
2.68% |
cellular response to hypoxia |
GO:0002209 |
2.68% |
behavioral defense response |
GO:0014743 |
2.68% |
regulation of muscle hypertrophy |
GO:0009798 |
2.68% |
axis specification |
GO:0090278 |
2.67% |
negative regulation of peptide hormone secretion |
GO:0060969 |
2.67% |
negative regulation of gene silencing |
GO:0051149 |
2.67% |
positive regulation of muscle cell differentiation |
GO:0071222 |
2.67% |
cellular response to lipopolysaccharide |
GO:0044060 |
2.66% |
regulation of endocrine process |
GO:0051057 |
2.66% |
positive regulation of small GTPase mediated signal transduction |
GO:0060078 |
2.66% |
regulation of postsynaptic membrane potential |
GO:0001658 |
2.66% |
branching involved in ureteric bud morphogenesis |
GO:0010803 |
2.66% |
regulation of tumor necrosis factor-mediated signaling pathway |
GO:0042306 |
2.66% |
regulation of protein import into nucleus |
GO:1905897 |
2.65% |
regulation of response to endoplasmic reticulum stress |
GO:0120031 |
2.65% |
plasma membrane bounded cell projection assembly |
GO:0016070 |
2.65% |
RNA metabolic process |
GO:0030239 |
2.64% |
myofibril assembly |
GO:0045104 |
2.64% |
intermediate filament cytoskeleton organization |
GO:0046716 |
2.64% |
muscle cell cellular homeostasis |
GO:0007605 |
2.64% |
sensory perception of sound |
GO:0008347 |
2.64% |
glial cell migration |
GO:0110111 |
2.64% |
negative regulation of animal organ morphogenesis |
GO:0035821 |
2.63% |
modification of morphology or physiology of other organism |
GO:0007190 |
2.63% |
activation of adenylate cyclase activity |
GO:0006026 |
2.62% |
aminoglycan catabolic process |
GO:2000378 |
2.61% |
negative regulation of reactive oxygen species metabolic process |
GO:0030879 |
2.61% |
mammary gland development |
GO:0072332 |
2.61% |
intrinsic apoptotic signaling pathway by p53 class mediator |
GO:0010332 |
2.61% |
response to gamma radiation |
GO:0002886 |
2.61% |
regulation of myeloid leukocyte mediated immunity |
GO:0031062 |
2.61% |
positive regulation of histone methylation |
GO:0030330 |
2.61% |
DNA damage response, signal transduction by p53 class mediator |
GO:0050995 |
2.61% |
negative regulation of lipid catabolic process |
GO:0002064 |
2.60% |
epithelial cell development |
GO:0071677 |
2.60% |
positive regulation of mononuclear cell migration |
GO:0030217 |
2.59% |
T cell differentiation |
GO:0098801 |
2.59% |
regulation of renal system process |
GO:0019233 |
2.59% |
sensory perception of pain |
GO:0050906 |
2.59% |
detection of stimulus involved in sensory perception |
GO:0048536 |
2.59% |
spleen development |
GO:0051155 |
2.58% |
positive regulation of striated muscle cell differentiation |
GO:0048638 |
2.58% |
regulation of developmental growth |
GO:0046488 |
2.58% |
phosphatidylinositol metabolic process |
GO:0034333 |
2.58% |
adherens junction assembly |
GO:0030097 |
2.57% |
hemopoiesis |
GO:0032886 |
2.57% |
regulation of microtubule-based process |
GO:1901186 |
2.57% |
positive regulation of ERBB signaling pathway |
GO:0040036 |
2.57% |
regulation of fibroblast growth factor receptor signaling pathway |
GO:0044403 |
2.56% |
symbiotic process |
GO:0070873 |
2.56% |
regulation of glycogen metabolic process |
GO:0032940 |
2.56% |
secretion by cell |
GO:0006865 |
2.56% |
amino acid transport |
GO:0097192 |
2.55% |
extrinsic apoptotic signaling pathway in absence of ligand |
GO:0045736 |
2.55% |
negative regulation of cyclin-dependent protein serine/threonine kinase activity |
GO:1901021 |
2.55% |
positive regulation of calcium ion transmembrane transporter activity |
GO:0032691 |
2.55% |
negative regulation of interleukin-1 beta production |
GO:0045589 |
2.54% |
regulation of regulatory T cell differentiation |
GO:0009620 |
2.54% |
response to fungus |
GO:0045661 |
2.54% |
regulation of myoblast differentiation |
GO:0006886 |
2.54% |
intracellular protein transport |
GO:0042113 |
2.53% |
B cell activation |
GO:0006836 |
2.53% |
neurotransmitter transport |
GO:0050870 |
2.53% |
positive regulation of T cell activation |
GO:0030595 |
2.53% |
leukocyte chemotaxis |
GO:0016071 |
2.53% |
mRNA metabolic process |
GO:0043244 |
2.53% |
regulation of protein complex disassembly |
GO:0051339 |
2.53% |
regulation of lyase activity |
GO:0030031 |
2.53% |
cell projection assembly |
GO:0045685 |
2.53% |
regulation of glial cell differentiation |
GO:0071384 |
2.51% |
cellular response to corticosteroid stimulus |
GO:0046579 |
2.51% |
positive regulation of Ras protein signal transduction |
GO:0042634 |
2.50% |
regulation of hair cycle |
GO:0034104 |
2.50% |
negative regulation of tissue remodeling |
GO:0044419 |
2.50% |
interspecies interaction between organisms |
GO:0001558 |
2.50% |
regulation of cell growth |
GO:0032892 |
2.50% |
positive regulation of organic acid transport |
GO:0007017 |
2.49% |
microtubule-based process |
GO:0090312 |
2.49% |
positive regulation of protein deacetylation |
GO:0032878 |
2.49% |
regulation of establishment or maintenance of cell polarity |
GO:0048660 |
2.49% |
regulation of smooth muscle cell proliferation |
GO:0050994 |
2.48% |
regulation of lipid catabolic process |
GO:1901998 |
2.48% |
toxin transport |
GO:1903671 |
2.48% |
negative regulation of sprouting angiogenesis |
GO:2000757 |
2.48% |
negative regulation of peptidyl-lysine acetylation |
GO:0031061 |
2.48% |
negative regulation of histone methylation |
GO:1903579 |
2.48% |
negative regulation of ATP metabolic process |
GO:0015672 |
2.48% |
monovalent inorganic cation transport |
GO:0032026 |
2.48% |
response to magnesium ion |
GO:1990830 |
2.47% |
cellular response to leukemia inhibitory factor |
GO:0009057 |
2.47% |
macromolecule catabolic process |
GO:0032943 |
2.47% |
mononuclear cell proliferation |
GO:0030866 |
2.47% |
cortical actin cytoskeleton organization |
GO:0071482 |
2.47% |
cellular response to light stimulus |
GO:0062149 |
2.47% |
detection of stimulus involved in sensory perception of pain |
GO:1903727 |
2.47% |
positive regulation of phospholipid metabolic process |
GO:1990823 |
2.46% |
response to leukemia inhibitory factor |
GO:0002790 |
2.46% |
peptide secretion |
GO:0045124 |
2.45% |
regulation of bone resorption |
GO:0016032 |
2.45% |
viral process |
GO:0010888 |
2.44% |
negative regulation of lipid storage |
GO:0034698 |
2.44% |
response to gonadotropin |
GO:0043388 |
2.44% |
positive regulation of DNA binding |
GO:0008038 |
2.44% |
neuron recognition |
GO:0017158 |
2.44% |
regulation of calcium ion-dependent exocytosis |
GO:0045109 |
2.44% |
intermediate filament organization |
GO:0023061 |
2.44% |
signal release |
GO:1905523 |
2.44% |
positive regulation of macrophage migration |
GO:0006970 |
2.44% |
response to osmotic stress |
GO:1903046 |
2.43% |
meiotic cell cycle process |
GO:2001237 |
2.43% |
negative regulation of extrinsic apoptotic signaling pathway |
GO:0014068 |
2.42% |
positive regulation of phosphatidylinositol 3-kinase signaling |
GO:0042596 |
2.42% |
fear response |
GO:0009886 |
2.42% |
post-embryonic animal morphogenesis |
GO:0033209 |
2.41% |
tumor necrosis factor-mediated signaling pathway |
GO:0048311 |
2.41% |
mitochondrion distribution |
GO:1903053 |
2.41% |
regulation of extracellular matrix organization |
GO:0010939 |
2.41% |
regulation of necrotic cell death |
GO:0051961 |
2.40% |
negative regulation of nervous system development |
GO:0085029 |
2.40% |
extracellular matrix assembly |
GO:0031424 |
2.40% |
keratinization |
GO:0038034 |
2.40% |
signal transduction in absence of ligand |
GO:0071371 |
2.39% |
cellular response to gonadotropin stimulus |
GO:0032781 |
2.39% |
positive regulation of ATPase activity |
GO:0046640 |
2.38% |
regulation of alpha-beta T cell proliferation |
GO:2001238 |
2.38% |
positive regulation of extrinsic apoptotic signaling pathway |
GO:0032653 |
2.38% |
regulation of interleukin-10 production |
GO:0050775 |
2.38% |
positive regulation of dendrite morphogenesis |
GO:0007588 |
2.37% |
excretion |
GO:0002824 |
2.36% |
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0046628 |
2.36% |
positive regulation of insulin receptor signaling pathway |
GO:0090184 |
2.36% |
positive regulation of kidney development |
GO:0006487 |
2.35% |
protein N-linked glycosylation |
GO:1904752 |
2.35% |
regulation of vascular associated smooth muscle cell migration |
GO:1904591 |
2.35% |
positive regulation of protein import |
GO:0150077 |
2.35% |
regulation of neuroinflammatory response |
GO:0046823 |
2.35% |
negative regulation of nucleocytoplasmic transport |
GO:2000516 |
2.35% |
positive regulation of CD4-positive, alpha-beta T cell activation |
GO:0002269 |
2.34% |
leukocyte activation involved in inflammatory response |
GO:0007179 |
2.34% |
transforming growth factor beta receptor signaling pathway |
GO:0045103 |
2.34% |
intermediate filament-based process |
GO:0016197 |
2.34% |
endosomal transport |
GO:0045087 |
2.34% |
innate immune response |
GO:0006027 |
2.33% |
glycosaminoglycan catabolic process |
GO:0006857 |
2.33% |
oligopeptide transport |
GO:0032673 |
2.32% |
regulation of interleukin-4 production |
GO:0000904 |
2.32% |
cell morphogenesis involved in differentiation |
GO:0043010 |
2.32% |
camera-type eye development |
GO:0045922 |
2.32% |
negative regulation of fatty acid metabolic process |
GO:0050920 |
2.32% |
regulation of chemotaxis |
GO:0003014 |
2.31% |
renal system process |
GO:0010594 |
2.31% |
regulation of endothelial cell migration |
GO:0051402 |
2.31% |
neuron apoptotic process |
GO:0019730 |
2.31% |
antimicrobial humoral response |
GO:0002026 |
2.31% |
regulation of the force of heart contraction |
GO:0016358 |
2.31% |
dendrite development |
GO:0097164 |
2.31% |
ammonium ion metabolic process |
GO:0032965 |
2.30% |
regulation of collagen biosynthetic process |
GO:0055092 |
2.30% |
sterol homeostasis |
GO:0032228 |
2.30% |
regulation of synaptic transmission, GABAergic |
GO:0002090 |
2.30% |
regulation of receptor internalization |
GO:0043588 |
2.30% |
skin development |
GO:0032008 |
2.30% |
positive regulation of TOR signaling |
GO:0048643 |
2.30% |
positive regulation of skeletal muscle tissue development |
GO:0002724 |
2.30% |
regulation of T cell cytokine production |
GO:1902116 |
2.30% |
negative regulation of organelle assembly |
GO:0045599 |
2.29% |
negative regulation of fat cell differentiation |
GO:0140352 |
2.29% |
export from cell |
GO:0035637 |
2.29% |
multicellular organismal signaling |
GO:0014823 |
2.29% |
response to activity |
GO:0014706 |
2.29% |
striated muscle tissue development |
GO:0048015 |
2.29% |
phosphatidylinositol-mediated signaling |
GO:0098926 |
2.29% |
postsynaptic signal transduction |
GO:0051154 |
2.28% |
negative regulation of striated muscle cell differentiation |
GO:0090208 |
2.28% |
positive regulation of triglyceride metabolic process |
GO:0051310 |
2.28% |
metaphase plate congression |
GO:0050820 |
2.28% |
positive regulation of coagulation |
GO:0060149 |
2.28% |
negative regulation of posttranscriptional gene silencing |
GO:0030194 |
2.28% |
positive regulation of blood coagulation |
GO:0008277 |
2.27% |
regulation of G protein-coupled receptor signaling pathway |
GO:0014742 |
2.27% |
positive regulation of muscle hypertrophy |
GO:0046676 |
2.27% |
negative regulation of insulin secretion |
GO:0071709 |
2.27% |
membrane assembly |
GO:0070328 |
2.27% |
triglyceride homeostasis |
GO:0022600 |
2.26% |
digestive system process |
GO:0051276 |
2.26% |
chromosome organization |
GO:1900744 |
2.26% |
regulation of p38MAPK cascade |
GO:0001656 |
2.26% |
metanephros development |
GO:0002526 |
2.26% |
acute inflammatory response |
GO:0044281 |
2.25% |
small molecule metabolic process |
GO:0007219 |
2.25% |
Notch signaling pathway |
GO:0045621 |
2.25% |
positive regulation of lymphocyte differentiation |
GO:0060840 |
2.25% |
artery development |
GO:0048259 |
2.24% |
regulation of receptor-mediated endocytosis |
GO:0070665 |
2.24% |
positive regulation of leukocyte proliferation |
GO:1900026 |
2.24% |
positive regulation of substrate adhesion-dependent cell spreading |
GO:0060359 |
2.23% |
response to ammonium ion |
GO:0007193 |
2.23% |
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway |
GO:0048103 |
2.23% |
somatic stem cell division |
GO:1900006 |
2.23% |
positive regulation of dendrite development |
GO:0019218 |
2.22% |
regulation of steroid metabolic process |
GO:0045912 |
2.22% |
negative regulation of carbohydrate metabolic process |
GO:0006665 |
2.22% |
sphingolipid metabolic process |
GO:0060967 |
2.22% |
negative regulation of gene silencing by RNA |
GO:0050905 |
2.22% |
neuromuscular process |
GO:0050768 |
2.22% |
negative regulation of neurogenesis |
GO:0048871 |
2.21% |
multicellular organismal homeostasis |
GO:0002637 |
2.21% |
regulation of immunoglobulin production |
GO:0032891 |
2.21% |
negative regulation of organic acid transport |
GO:0090049 |
2.20% |
regulation of cell migration involved in sprouting angiogenesis |
GO:0010517 |
2.20% |
regulation of phospholipase activity |
GO:0007205 |
2.20% |
protein kinase C-activating G protein-coupled receptor signaling pathway |
GO:0044282 |
2.20% |
small molecule catabolic process |
GO:1903214 |
2.20% |
regulation of protein targeting to mitochondrion |
GO:0001912 |
2.19% |
positive regulation of leukocyte mediated cytotoxicity |
GO:0002888 |
2.19% |
positive regulation of myeloid leukocyte mediated immunity |
GO:0007269 |
2.19% |
neurotransmitter secretion |
GO:0002922 |
2.17% |
positive regulation of humoral immune response |
GO:1901185 |
2.17% |
negative regulation of ERBB signaling pathway |
GO:2001251 |
2.16% |
negative regulation of chromosome organization |
GO:0061077 |
2.16% |
chaperone-mediated protein folding |
GO:0010631 |
2.15% |
epithelial cell migration |
GO:0048731 |
2.15% |
system development |
GO:0033077 |
2.15% |
T cell differentiation in thymus |
GO:1900048 |
2.15% |
positive regulation of hemostasis |
GO:0002764 |
2.15% |
immune response-regulating signaling pathway |
GO:0097120 |
2.14% |
receptor localization to synapse |
GO:0050829 |
2.14% |
defense response to Gram-negative bacterium |
GO:0055078 |
2.14% |
sodium ion homeostasis |
GO:0006582 |
2.14% |
melanin metabolic process |
GO:0001822 |
2.14% |
kidney development |
GO:0045165 |
2.14% |
cell fate commitment |
GO:0098754 |
2.14% |
detoxification |
GO:2000273 |
2.14% |
positive regulation of signaling receptor activity |
GO:0009644 |
2.14% |
response to high light intensity |
GO:0033688 |
2.13% |
regulation of osteoblast proliferation |
GO:0002711 |
2.13% |
positive regulation of T cell mediated immunity |
GO:0010632 |
2.13% |
regulation of epithelial cell migration |
GO:0007612 |
2.13% |
learning |
GO:0002757 |
2.13% |
immune response-activating signal transduction |
GO:0002686 |
2.13% |
negative regulation of leukocyte migration |
GO:0009306 |
2.12% |
protein secretion |
GO:0090100 |
2.12% |
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0006091 |
2.12% |
generation of precursor metabolites and energy |
GO:2000401 |
2.12% |
regulation of lymphocyte migration |
GO:2000310 |
2.12% |
regulation of NMDA receptor activity |
GO:0007214 |
2.11% |
gamma-aminobutyric acid signaling pathway |
GO:0051955 |
2.10% |
regulation of amino acid transport |
GO:0034620 |
2.10% |
cellular response to unfolded protein |
GO:1990928 |
2.10% |
response to amino acid starvation |
GO:0043300 |
2.10% |
regulation of leukocyte degranulation |
GO:0042304 |
2.10% |
regulation of fatty acid biosynthetic process |
GO:0046651 |
2.10% |
lymphocyte proliferation |
GO:0034198 |
2.10% |
cellular response to amino acid starvation |
GO:0030509 |
2.09% |
BMP signaling pathway |
GO:1902019 |
2.09% |
regulation of cilium-dependent cell motility |
GO:0046683 |
2.09% |
response to organophosphorus |
GO:0042423 |
2.09% |
catecholamine biosynthetic process |
GO:0061900 |
2.09% |
glial cell activation |
GO:0034332 |
2.09% |
adherens junction organization |
GO:0010467 |
2.09% |
gene expression |
GO:1902904 |
2.09% |
negative regulation of supramolecular fiber organization |
GO:0033233 |
2.08% |
regulation of protein sumoylation |
GO:0035025 |
2.08% |
positive regulation of Rho protein signal transduction |
GO:0048017 |
2.08% |
inositol lipid-mediated signaling |
GO:0006913 |
2.08% |
nucleocytoplasmic transport |
GO:2001222 |
2.08% |
regulation of neuron migration |
GO:0002768 |
2.08% |
immune response-regulating cell surface receptor signaling pathway |
GO:0006953 |
2.07% |
acute-phase response |
GO:0016042 |
2.07% |
lipid catabolic process |
GO:0006914 |
2.07% |
autophagy |
GO:0001778 |
2.07% |
plasma membrane repair |
GO:0032354 |
2.07% |
response to follicle-stimulating hormone |
GO:0006658 |
2.06% |
phosphatidylserine metabolic process |
GO:0051571 |
2.06% |
positive regulation of histone H3-K4 methylation |
GO:0043901 |
2.06% |
negative regulation of multi-organism process |
GO:0006888 |
2.06% |
endoplasmic reticulum to Golgi vesicle-mediated transport |
GO:0043407 |
2.06% |
negative regulation of MAP kinase activity |
GO:0002244 |
2.06% |
hematopoietic progenitor cell differentiation |
GO:0043516 |
2.06% |
regulation of DNA damage response, signal transduction by p53 class mediator |
GO:0006820 |
2.05% |
anion transport |
GO:0061919 |
2.05% |
process utilizing autophagic mechanism |
GO:0031338 |
2.05% |
regulation of vesicle fusion |
GO:0031579 |
2.05% |
membrane raft organization |
GO:0014065 |
2.05% |
phosphatidylinositol 3-kinase signaling |
GO:1902692 |
2.05% |
regulation of neuroblast proliferation |
GO:0002792 |
2.05% |
negative regulation of peptide secretion |
GO:0007212 |
2.05% |
dopamine receptor signaling pathway |
GO:0010613 |
2.04% |
positive regulation of cardiac muscle hypertrophy |
GO:0090322 |
2.04% |
regulation of superoxide metabolic process |
GO:0042116 |
2.04% |
macrophage activation |
GO:0030104 |
2.04% |
water homeostasis |
GO:0002521 |
2.04% |
leukocyte differentiation |
GO:1900101 |
2.04% |
regulation of endoplasmic reticulum unfolded protein response |
GO:0033003 |
2.04% |
regulation of mast cell activation |
GO:2000272 |
2.04% |
negative regulation of signaling receptor activity |
GO:0071402 |
2.04% |
cellular response to lipoprotein particle stimulus |
GO:1901381 |
2.03% |
positive regulation of potassium ion transmembrane transport |
GO:0048469 |
2.03% |
cell maturation |
GO:1902932 |
2.03% |
positive regulation of alcohol biosynthetic process |
GO:1903556 |
2.03% |
negative regulation of tumor necrosis factor superfamily cytokine production |
GO:0043620 |
2.03% |
regulation of DNA-templated transcription in response to stress |
GO:0051169 |
2.03% |
nuclear transport |
GO:0032434 |
2.03% |
regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO:0032148 |
2.03% |
activation of protein kinase B activity |
GO:0002639 |
2.02% |
positive regulation of immunoglobulin production |
GO:0048634 |
2.02% |
regulation of muscle organ development |
GO:1990266 |
2.02% |
neutrophil migration |
GO:0055114 |
2.02% |
oxidation-reduction process |
GO:2000311 |
2.02% |
regulation of AMPA receptor activity |
GO:0016572 |
2.02% |
histone phosphorylation |
GO:0002832 |
2.01% |
negative regulation of response to biotic stimulus |
GO:0030183 |
2.01% |
B cell differentiation |
GO:2000242 |
2.00% |
negative regulation of reproductive process |
GO:0055094 |
2.00% |
response to lipoprotein particle |
GO:0051965 |
2.00% |
positive regulation of synapse assembly |
GO:0051957 |
2.00% |
positive regulation of amino acid transport |
GO:2000058 |
1.99% |
regulation of ubiquitin-dependent protein catabolic process |
GO:0045214 |
1.99% |
sarcomere organization |
GO:0016202 |
1.99% |
regulation of striated muscle tissue development |
GO:0021795 |
1.99% |
cerebral cortex cell migration |
GO:0006356 |
1.99% |
regulation of transcription by RNA polymerase I |
GO:0030098 |
1.99% |
lymphocyte differentiation |
GO:0044782 |
1.98% |
cilium organization |
GO:1902229 |
1.98% |
regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
GO:0032271 |
1.98% |
regulation of protein polymerization |
GO:0032652 |
1.98% |
regulation of interleukin-1 production |
GO:0032715 |
1.97% |
negative regulation of interleukin-6 production |
GO:0006641 |
1.97% |
triglyceride metabolic process |
GO:0048169 |
1.97% |
regulation of long-term neuronal synaptic plasticity |
GO:0045639 |
1.97% |
positive regulation of myeloid cell differentiation |
GO:2000514 |
1.97% |
regulation of CD4-positive, alpha-beta T cell activation |
GO:1902749 |
1.97% |
regulation of cell cycle G2/M phase transition |
GO:0001843 |
1.97% |
neural tube closure |
GO:0060071 |
1.97% |
Wnt signaling pathway, planar cell polarity pathway |
GO:0002720 |
1.97% |
positive regulation of cytokine production involved in immune response |
GO:2000352 |
1.97% |
negative regulation of endothelial cell apoptotic process |
GO:0043647 |
1.97% |
inositol phosphate metabolic process |
GO:0010837 |
1.96% |
regulation of keratinocyte proliferation |
GO:1901617 |
1.96% |
organic hydroxy compound biosynthetic process |
GO:0002274 |
1.96% |
myeloid leukocyte activation |
GO:0042742 |
1.96% |
defense response to bacterium |
GO:0035967 |
1.95% |
cellular response to topologically incorrect protein |
GO:1900015 |
1.95% |
regulation of cytokine production involved in inflammatory response |
GO:0001505 |
1.95% |
regulation of neurotransmitter levels |
GO:0098693 |
1.95% |
regulation of synaptic vesicle cycle |
GO:0043903 |
1.95% |
regulation of symbiosis, encompassing mutualism through parasitism |
GO:0035902 |
1.95% |
response to immobilization stress |
GO:0070997 |
1.95% |
neuron death |
GO:0016311 |
1.94% |
dephosphorylation |
GO:0060271 |
1.94% |
cilium assembly |
GO:0001774 |
1.94% |
microglial cell activation |
GO:1904705 |
1.94% |
regulation of vascular smooth muscle cell proliferation |
GO:0010721 |
1.94% |
negative regulation of cell development |
GO:0045428 |
1.93% |
regulation of nitric oxide biosynthetic process |
GO:0060688 |
1.93% |
regulation of morphogenesis of a branching structure |
GO:0042632 |
1.93% |
cholesterol homeostasis |
GO:0097530 |
1.93% |
granulocyte migration |
GO:0019752 |
1.93% |
carboxylic acid metabolic process |
GO:0032928 |
1.92% |
regulation of superoxide anion generation |
GO:0055093 |
1.92% |
response to hyperoxia |
GO:0016239 |
1.92% |
positive regulation of macroautophagy |
GO:0045058 |
1.92% |
T cell selection |
GO:1903831 |
1.92% |
signal transduction involved in cellular response to ammonium ion |
GO:0015711 |
1.92% |
organic anion transport |
GO:0035966 |
1.91% |
response to topologically incorrect protein |
GO:0022612 |
1.91% |
gland morphogenesis |
GO:0070507 |
1.91% |
regulation of microtubule cytoskeleton organization |
GO:0097529 |
1.91% |
myeloid leukocyte migration |
GO:0046467 |
1.91% |
membrane lipid biosynthetic process |
GO:0032197 |
1.91% |
transposition, RNA-mediated |
GO:0051591 |
1.91% |
response to cAMP |
GO:0009791 |
1.91% |
post-embryonic development |
GO:0051216 |
1.90% |
cartilage development |
GO:1903792 |
1.90% |
negative regulation of anion transport |
GO:0036296 |
1.90% |
response to increased oxygen levels |
GO:0045981 |
1.90% |
positive regulation of nucleotide metabolic process |
GO:2000463 |
1.90% |
positive regulation of excitatory postsynaptic potential |
GO:0009110 |
1.90% |
vitamin biosynthetic process |
GO:0003007 |
1.90% |
heart morphogenesis |
GO:1903421 |
1.89% |
regulation of synaptic vesicle recycling |
GO:0060759 |
1.89% |
regulation of response to cytokine stimulus |
GO:0048193 |
1.89% |
Golgi vesicle transport |
GO:0072091 |
1.89% |
regulation of stem cell proliferation |
GO:0055002 |
1.88% |
striated muscle cell development |
GO:0001654 |
1.88% |
eye development |
GO:2001243 |
1.88% |
negative regulation of intrinsic apoptotic signaling pathway |
GO:0048568 |
1.88% |
embryonic organ development |
GO:0035592 |
1.88% |
establishment of protein localization to extracellular region |
GO:0061001 |
1.87% |
regulation of dendritic spine morphogenesis |
GO:2000379 |
1.87% |
positive regulation of reactive oxygen species metabolic process |
GO:0051303 |
1.87% |
establishment of chromosome localization |
GO:0060706 |
1.87% |
cell differentiation involved in embryonic placenta development |
GO:0090200 |
1.87% |
positive regulation of release of cytochrome c from mitochondria |
GO:0019827 |
1.87% |
stem cell population maintenance |
GO:1900544 |
1.86% |
positive regulation of purine nucleotide metabolic process |
GO:1900078 |
1.86% |
positive regulation of cellular response to insulin stimulus |
GO:0006941 |
1.86% |
striated muscle contraction |
GO:0120161 |
1.86% |
regulation of cold-induced thermogenesis |
GO:0042104 |
1.86% |
positive regulation of activated T cell proliferation |
GO:0048563 |
1.86% |
post-embryonic animal organ morphogenesis |
GO:0033561 |
1.86% |
regulation of water loss via skin |
GO:1904893 |
1.86% |
negative regulation of receptor signaling pathway via STAT |
GO:0055090 |
1.86% |
acylglycerol homeostasis |
GO:0060632 |
1.86% |
regulation of microtubule-based movement |
GO:0032946 |
1.85% |
positive regulation of mononuclear cell proliferation |
GO:1902473 |
1.85% |
regulation of protein localization to synapse |
GO:0006890 |
1.85% |
retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum |
GO:0043457 |
1.85% |
regulation of cellular respiration |
GO:0003015 |
1.85% |
heart process |
GO:0009395 |
1.85% |
phospholipid catabolic process |
GO:0002758 |
1.84% |
innate immune response-activating signal transduction |
GO:0061515 |
1.84% |
myeloid cell development |
GO:0010743 |
1.84% |
regulation of macrophage derived foam cell differentiation |
GO:0006643 |
1.84% |
membrane lipid metabolic process |
GO:0095500 |
1.84% |
acetylcholine receptor signaling pathway |
GO:0065005 |
1.83% |
protein-lipid complex assembly |
GO:0045833 |
1.83% |
negative regulation of lipid metabolic process |
GO:0003009 |
1.83% |
skeletal muscle contraction |
GO:0032720 |
1.82% |
negative regulation of tumor necrosis factor production |
GO:0045598 |
1.82% |
regulation of fat cell differentiation |
GO:0090175 |
1.82% |
regulation of establishment of planar polarity |
GO:0045638 |
1.82% |
negative regulation of myeloid cell differentiation |
GO:0015931 |
1.82% |
nucleobase-containing compound transport |
GO:0006893 |
1.82% |
Golgi to plasma membrane transport |
GO:0050999 |
1.82% |
regulation of nitric-oxide synthase activity |
GO:0010714 |
1.82% |
positive regulation of collagen metabolic process |
GO:0010927 |
1.81% |
cellular component assembly involved in morphogenesis |
GO:0030947 |
1.81% |
regulation of vascular endothelial growth factor receptor signaling pathway |
GO:0015844 |
1.81% |
monoamine transport |
GO:0051150 |
1.81% |
regulation of smooth muscle cell differentiation |
GO:0031098 |
1.81% |
stress-activated protein kinase signaling cascade |
GO:0010259 |
1.81% |
multicellular organism aging |
GO:0007286 |
1.81% |
spermatid development |
GO:0014075 |
1.81% |
response to amine |
GO:0010001 |
1.81% |
glial cell differentiation |
GO:0051053 |
1.80% |
negative regulation of DNA metabolic process |
GO:1902893 |
1.80% |
regulation of pri-miRNA transcription by RNA polymerase II |
GO:0043414 |
1.80% |
macromolecule methylation |
GO:0071675 |
1.80% |
regulation of mononuclear cell migration |
GO:0060079 |
1.79% |
excitatory postsynaptic potential |
GO:0071692 |
1.79% |
protein localization to extracellular region |
GO:0007602 |
1.79% |
phototransduction |
GO:0051236 |
1.79% |
establishment of RNA localization |
GO:1902414 |
1.79% |
protein localization to cell junction |
GO:0050796 |
1.79% |
regulation of insulin secretion |
GO:1903363 |
1.78% |
negative regulation of cellular protein catabolic process |
GO:0032990 |
1.78% |
cell part morphogenesis |
GO:1904019 |
1.78% |
epithelial cell apoptotic process |
GO:0006413 |
1.78% |
translational initiation |
GO:0002719 |
1.77% |
negative regulation of cytokine production involved in immune response |
GO:0044283 |
1.77% |
small molecule biosynthetic process |
GO:0001756 |
1.77% |
somitogenesis |
GO:0042462 |
1.77% |
eye photoreceptor cell development |
GO:0001657 |
1.77% |
ureteric bud development |
GO:0045844 |
1.77% |
positive regulation of striated muscle tissue development |
GO:0035282 |
1.76% |
segmentation |
GO:0099643 |
1.76% |
signal release from synapse |
GO:0061005 |
1.76% |
cell differentiation involved in kidney development |
GO:0043507 |
1.76% |
positive regulation of JUN kinase activity |
GO:0090596 |
1.75% |
sensory organ morphogenesis |
GO:0021885 |
1.75% |
forebrain cell migration |
GO:0043618 |
1.75% |
regulation of transcription from RNA polymerase II promoter in response to stress |
GO:1902993 |
1.75% |
positive regulation of amyloid precursor protein catabolic process |
GO:0050657 |
1.74% |
nucleic acid transport |
GO:0071772 |
1.74% |
response to BMP |
GO:0002429 |
1.74% |
immune response-activating cell surface receptor signaling pathway |
GO:0034645 |
1.74% |
cellular macromolecule biosynthetic process |
GO:0006470 |
1.74% |
protein dephosphorylation |
GO:0001975 |
1.74% |
response to amphetamine |
GO:0071480 |
1.73% |
cellular response to gamma radiation |
GO:0008643 |
1.73% |
carbohydrate transport |
GO:0072676 |
1.73% |
lymphocyte migration |
GO:0045669 |
1.73% |
positive regulation of osteoblast differentiation |
GO:0035295 |
1.73% |
tube development |
GO:0007623 |
1.73% |
circadian rhythm |
GO:0014031 |
1.73% |
mesenchymal cell development |
GO:0010661 |
1.73% |
positive regulation of muscle cell apoptotic process |
GO:0001562 |
1.73% |
response to protozoan |
GO:0051650 |
1.72% |
establishment of vesicle localization |
GO:0001569 |
1.72% |
branching involved in blood vessel morphogenesis |
GO:0010862 |
1.72% |
positive regulation of pathway-restricted SMAD protein phosphorylation |
GO:0031640 |
1.72% |
killing of cells of other organism |
GO:0002726 |
1.72% |
positive regulation of T cell cytokine production |
GO:0050658 |
1.72% |
RNA transport |
GO:0007034 |
1.72% |
vacuolar transport |
GO:0031109 |
1.72% |
microtubule polymerization or depolymerization |
GO:0007614 |
1.71% |
short-term memory |
GO:2000243 |
1.71% |
positive regulation of reproductive process |
GO:0060560 |
1.71% |
developmental growth involved in morphogenesis |
GO:0045927 |
1.71% |
positive regulation of growth |
GO:0050766 |
1.71% |
positive regulation of phagocytosis |
GO:0044764 |
1.70% |
multi-organism cellular process |
GO:0060122 |
1.70% |
inner ear receptor cell stereocilium organization |
GO:0009713 |
1.70% |
catechol-containing compound biosynthetic process |
GO:0034123 |
1.70% |
positive regulation of toll-like receptor signaling pathway |
GO:0030728 |
1.70% |
ovulation |
GO:0060348 |
1.70% |
bone development |
GO:0010884 |
1.70% |
positive regulation of lipid storage |
GO:0030833 |
1.70% |
regulation of actin filament polymerization |
GO:0098727 |
1.70% |
maintenance of cell number |
GO:0045824 |
1.70% |
negative regulation of innate immune response |
GO:0045663 |
1.70% |
positive regulation of myoblast differentiation |
GO:0043413 |
1.70% |
macromolecule glycosylation |
GO:2000404 |
1.69% |
regulation of T cell migration |
GO:2000191 |
1.69% |
regulation of fatty acid transport |
GO:0010042 |
1.69% |
response to manganese ion |
GO:1902074 |
1.69% |
response to salt |
GO:0006304 |
1.69% |
DNA modification |
GO:0045089 |
1.69% |
positive regulation of innate immune response |
GO:0048661 |
1.68% |
positive regulation of smooth muscle cell proliferation |
GO:0045923 |
1.68% |
positive regulation of fatty acid metabolic process |
GO:0032535 |
1.68% |
regulation of cellular component size |
GO:0048562 |
1.68% |
embryonic organ morphogenesis |
GO:0007601 |
1.68% |
visual perception |
GO:0014059 |
1.68% |
regulation of dopamine secretion |
GO:1903573 |
1.68% |
negative regulation of response to endoplasmic reticulum stress |
GO:0009101 |
1.67% |
glycoprotein biosynthetic process |
GO:0051651 |
1.67% |
maintenance of location in cell |
GO:1902042 |
1.67% |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO:0072593 |
1.67% |
reactive oxygen species metabolic process |
GO:0001837 |
1.67% |
epithelial to mesenchymal transition |
GO:0006611 |
1.67% |
protein export from nucleus |
GO:0051017 |
1.66% |
actin filament bundle assembly |
GO:0097485 |
1.66% |
neuron projection guidance |
GO:0008406 |
1.66% |
gonad development |
GO:0043001 |
1.66% |
Golgi to plasma membrane protein transport |
GO:0071870 |
1.66% |
cellular response to catecholamine stimulus |
GO:0045943 |
1.65% |
positive regulation of transcription by RNA polymerase I |
GO:0071773 |
1.65% |
cellular response to BMP stimulus |
GO:0032885 |
1.65% |
regulation of polysaccharide biosynthetic process |
GO:0050671 |
1.65% |
positive regulation of lymphocyte proliferation |
GO:0047484 |
1.65% |
regulation of response to osmotic stress |
GO:0021915 |
1.65% |
neural tube development |
GO:0030258 |
1.65% |
lipid modification |
GO:0001539 |
1.65% |
cilium or flagellum-dependent cell motility |
GO:1903524 |
1.65% |
positive regulation of blood circulation |
GO:0046326 |
1.65% |
positive regulation of glucose import |
GO:1901565 |
1.65% |
organonitrogen compound catabolic process |
GO:0030587 |
1.64% |
sorocarp development |
GO:0051589 |
1.64% |
negative regulation of neurotransmitter transport |
GO:0042398 |
1.64% |
cellular modified amino acid biosynthetic process |
GO:0040019 |
1.64% |
positive regulation of embryonic development |
GO:0006897 |
1.64% |
endocytosis |
GO:0032642 |
1.64% |
regulation of chemokine production |
GO:0031122 |
1.64% |
cytoplasmic microtubule organization |
GO:1903427 |
1.64% |
negative regulation of reactive oxygen species biosynthetic process |
GO:0009566 |
1.64% |
fertilization |
GO:0061844 |
1.64% |
antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0046324 |
1.64% |
regulation of glucose import |
GO:1901678 |
1.64% |
iron coordination entity transport |
GO:1901861 |
1.64% |
regulation of muscle tissue development |
GO:0042692 |
1.64% |
muscle cell differentiation |
GO:0050885 |
1.64% |
neuromuscular process controlling balance |
GO:1903649 |
1.63% |
regulation of cytoplasmic transport |
GO:0040014 |
1.63% |
regulation of multicellular organism growth |
GO:0045744 |
1.63% |
negative regulation of G protein-coupled receptor signaling pathway |
GO:0032651 |
1.63% |
regulation of interleukin-1 beta production |
GO:0030307 |
1.63% |
positive regulation of cell growth |
GO:1905521 |
1.63% |
regulation of macrophage migration |
GO:0051648 |
1.63% |
vesicle localization |
GO:0043552 |
1.63% |
positive regulation of phosphatidylinositol 3-kinase activity |
GO:0033574 |
1.63% |
response to testosterone |
GO:0051570 |
1.63% |
regulation of histone H3-K9 methylation |
GO:0051817 |
1.62% |
modification of morphology or physiology of other organism involved in symbiotic interaction |
GO:0045684 |
1.62% |
positive regulation of epidermis development |
GO:0031032 |
1.62% |
actomyosin structure organization |
GO:0030148 |
1.62% |
sphingolipid biosynthetic process |
GO:0048662 |
1.62% |
negative regulation of smooth muscle cell proliferation |
GO:0010866 |
1.62% |
regulation of triglyceride biosynthetic process |
GO:0010822 |
1.62% |
positive regulation of mitochondrion organization |
GO:0045776 |
1.61% |
negative regulation of blood pressure |
GO:1901739 |
1.61% |
regulation of myoblast fusion |
GO:0019098 |
1.61% |
reproductive behavior |
GO:0008064 |
1.61% |
regulation of actin polymerization or depolymerization |
GO:0050795 |
1.61% |
regulation of behavior |
GO:0048641 |
1.61% |
regulation of skeletal muscle tissue development |
GO:0051403 |
1.61% |
stress-activated MAPK cascade |
GO:0048636 |
1.61% |
positive regulation of muscle organ development |
GO:0002052 |
1.61% |
positive regulation of neuroblast proliferation |
GO:0030199 |
1.61% |
collagen fibril organization |
GO:0009593 |
1.61% |
detection of chemical stimulus |
GO:1903901 |
1.61% |
negative regulation of viral life cycle |
GO:0050918 |
1.61% |
positive chemotaxis |
GO:0060968 |
1.60% |
regulation of gene silencing |
GO:0010827 |
1.60% |
regulation of glucose transmembrane transport |
GO:0017085 |
1.60% |
response to insecticide |
GO:0045686 |
1.60% |
negative regulation of glial cell differentiation |
GO:1902895 |
1.60% |
positive regulation of pri-miRNA transcription by RNA polymerase II |
GO:0048666 |
1.60% |
neuron development |
GO:0001959 |
1.60% |
regulation of cytokine-mediated signaling pathway |
GO:0007411 |
1.60% |
axon guidance |
GO:0044062 |
1.59% |
regulation of excretion |
GO:1902930 |
1.59% |
regulation of alcohol biosynthetic process |
GO:0002675 |
1.59% |
positive regulation of acute inflammatory response |
GO:0043302 |
1.59% |
positive regulation of leukocyte degranulation |
GO:0051954 |
1.59% |
positive regulation of amine transport |
GO:0030216 |
1.59% |
keratinocyte differentiation |
GO:0010043 |
1.59% |
response to zinc ion |
GO:0006892 |
1.59% |
post-Golgi vesicle-mediated transport |
GO:0030855 |
1.59% |
epithelial cell differentiation |
GO:0048709 |
1.59% |
oligodendrocyte differentiation |
GO:0003382 |
1.58% |
epithelial cell morphogenesis |
GO:1903845 |
1.58% |
negative regulation of cellular response to transforming growth factor beta stimulus |
GO:0030218 |
1.58% |
erythrocyte differentiation |
GO:0002253 |
1.58% |
activation of immune response |
GO:0050953 |
1.58% |
sensory perception of light stimulus |
GO:0015918 |
1.58% |
sterol transport |
GO:0097352 |
1.57% |
autophagosome maturation |
GO:0044364 |
1.57% |
disruption of cells of other organism |
GO:0072347 |
1.57% |
response to anesthetic |
GO:0001578 |
1.57% |
microtubule bundle formation |
GO:0030512 |
1.57% |
negative regulation of transforming growth factor beta receptor signaling pathway |
GO:0036119 |
1.57% |
response to platelet-derived growth factor |
GO:1901362 |
1.57% |
organic cyclic compound biosynthetic process |
GO:0034605 |
1.57% |
cellular response to heat |
GO:0048705 |
1.57% |
skeletal system morphogenesis |
GO:0017015 |
1.56% |
regulation of transforming growth factor beta receptor signaling pathway |
GO:0043652 |
1.56% |
engulfment of apoptotic cell |
GO:1904262 |
1.56% |
negative regulation of TORC1 signaling |
GO:0007076 |
1.56% |
mitotic chromosome condensation |
GO:0007281 |
1.56% |
germ cell development |
GO:0033006 |
1.56% |
regulation of mast cell activation involved in immune response |
GO:0060964 |
1.56% |
regulation of gene silencing by miRNA |
GO:0008360 |
1.56% |
regulation of cell shape |
GO:0022029 |
1.56% |
telencephalon cell migration |
GO:0061572 |
1.55% |
actin filament bundle organization |
GO:0010718 |
1.55% |
positive regulation of epithelial to mesenchymal transition |
GO:0014014 |
1.55% |
negative regulation of gliogenesis |
GO:0014812 |
1.55% |
muscle cell migration |
GO:0046638 |
1.55% |
positive regulation of alpha-beta T cell differentiation |
GO:0007399 |
1.55% |
nervous system development |
GO:0050931 |
1.55% |
pigment cell differentiation |
GO:0045332 |
1.54% |
phospholipid translocation |
GO:0001889 |
1.54% |
liver development |
GO:0010770 |
1.54% |
positive regulation of cell morphogenesis involved in differentiation |
GO:0045667 |
1.54% |
regulation of osteoblast differentiation |
GO:0090702 |
1.54% |
non-reproductive fruiting body development |
GO:0032259 |
1.54% |
methylation |
GO:1990090 |
1.54% |
cellular response to nerve growth factor stimulus |
GO:0001895 |
1.53% |
retina homeostasis |
GO:0021533 |
1.53% |
cell differentiation in hindbrain |
GO:0036120 |
1.53% |
cellular response to platelet-derived growth factor stimulus |
GO:0051443 |
1.53% |
positive regulation of ubiquitin-protein transferase activity |
GO:0071548 |
1.53% |
response to dexamethasone |
GO:0014910 |
1.53% |
regulation of smooth muscle cell migration |
GO:0030278 |
1.53% |
regulation of ossification |
GO:0051168 |
1.53% |
nuclear export |
GO:0045723 |
1.52% |
positive regulation of fatty acid biosynthetic process |
GO:0071868 |
1.52% |
cellular response to monoamine stimulus |
GO:0045616 |
1.52% |
regulation of keratinocyte differentiation |
GO:0043030 |
1.52% |
regulation of macrophage activation |
GO:0035924 |
1.52% |
cellular response to vascular endothelial growth factor stimulus |
GO:0007626 |
1.52% |
locomotory behavior |
GO:0008380 |
1.52% |
RNA splicing |
GO:0046620 |
1.51% |
regulation of organ growth |
GO:0051148 |
1.51% |
negative regulation of muscle cell differentiation |
GO:1905710 |
1.51% |
positive regulation of membrane permeability |
GO:0007127 |
1.51% |
meiosis I |
GO:0008306 |
1.51% |
associative learning |
GO:1905562 |
1.50% |
regulation of vascular endothelial cell proliferation |
GO:1900745 |
1.50% |
positive regulation of p38MAPK cascade |
GO:0043562 |
1.50% |
cellular response to nitrogen levels |
GO:0001541 |
1.50% |
ovarian follicle development |
GO:2001239 |
1.50% |
regulation of extrinsic apoptotic signaling pathway in absence of ligand |
GO:0006066 |
1.50% |
alcohol metabolic process |
GO:0009583 |
1.50% |
detection of light stimulus |
GO:1901018 |
1.50% |
positive regulation of potassium ion transmembrane transporter activity |
GO:1903051 |
1.50% |
negative regulation of proteolysis involved in cellular protein catabolic process |
GO:0022617 |
1.49% |
extracellular matrix disassembly |
GO:0043124 |
1.49% |
negative regulation of I-kappaB kinase/NF-kappaB signaling |
GO:0097581 |
1.49% |
lamellipodium organization |
GO:0022900 |
1.49% |
electron transport chain |
GO:0010575 |
1.48% |
positive regulation of vascular endothelial growth factor production |
GO:0071549 |
1.48% |
cellular response to dexamethasone stimulus |
GO:1905953 |
1.48% |
negative regulation of lipid localization |
GO:0007224 |
1.48% |
smoothened signaling pathway |
GO:0032722 |
1.48% |
positive regulation of chemokine production |
GO:0009059 |
1.47% |
macromolecule biosynthetic process |
GO:0060674 |
1.47% |
placenta blood vessel development |
GO:0042551 |
1.47% |
neuron maturation |
GO:0045665 |
1.47% |
negative regulation of neuron differentiation |
GO:0001667 |
1.47% |
ameboidal-type cell migration |
GO:0007519 |
1.47% |
skeletal muscle tissue development |
GO:0006639 |
1.47% |
acylglycerol metabolic process |
GO:0001914 |
1.47% |
regulation of T cell mediated cytotoxicity |
GO:0050000 |
1.47% |
chromosome localization |
GO:0031532 |
1.47% |
actin cytoskeleton reorganization |
GO:0060147 |
1.47% |
regulation of posttranscriptional gene silencing |
GO:0072163 |
1.46% |
mesonephric epithelium development |
GO:0032986 |
1.46% |
protein-DNA complex disassembly |
GO:0032735 |
1.46% |
positive regulation of interleukin-12 production |
GO:0034204 |
1.46% |
lipid translocation |
GO:0060325 |
1.46% |
face morphogenesis |
GO:0048710 |
1.46% |
regulation of astrocyte differentiation |
GO:0015696 |
1.46% |
ammonium transport |
GO:0043090 |
1.46% |
amino acid import |
GO:0003002 |
1.46% |
regionalization |
GO:0040029 |
1.46% |
regulation of gene expression, epigenetic |
GO:0006082 |
1.45% |
organic acid metabolic process |
GO:0061337 |
1.45% |
cardiac conduction |
GO:0008589 |
1.45% |
regulation of smoothened signaling pathway |
GO:0032963 |
1.45% |
collagen metabolic process |
GO:0030514 |
1.45% |
negative regulation of BMP signaling pathway |
GO:0046631 |
1.45% |
alpha-beta T cell activation |
GO:0018345 |
1.45% |
protein palmitoylation |
GO:0098751 |
1.45% |
bone cell development |
GO:0030832 |
1.45% |
regulation of actin filament length |
GO:0050832 |
1.45% |
defense response to fungus |
GO:1903428 |
1.45% |
positive regulation of reactive oxygen species biosynthetic process |
GO:0099024 |
1.45% |
plasma membrane invagination |
GO:0003333 |
1.45% |
amino acid transmembrane transport |
GO:0002820 |
1.44% |
negative regulation of adaptive immune response |
GO:0046634 |
1.44% |
regulation of alpha-beta T cell activation |
GO:0032881 |
1.44% |
regulation of polysaccharide metabolic process |
GO:0071827 |
1.44% |
plasma lipoprotein particle organization |
GO:0048008 |
1.44% |
platelet-derived growth factor receptor signaling pathway |
GO:0072164 |
1.44% |
mesonephric tubule development |
GO:1905153 |
1.44% |
regulation of membrane invagination |
GO:0021983 |
1.44% |
pituitary gland development |
GO:0017144 |
1.43% |
drug metabolic process |
GO:0009948 |
1.43% |
anterior/posterior axis specification |
GO:0045879 |
1.43% |
negative regulation of smoothened signaling pathway |
GO:0071559 |
1.43% |
response to transforming growth factor beta |
GO:0001956 |
1.43% |
positive regulation of neurotransmitter secretion |
GO:0060429 |
1.42% |
epithelium development |
GO:0050770 |
1.42% |
regulation of axonogenesis |
GO:0061245 |
1.42% |
establishment or maintenance of bipolar cell polarity |
GO:0032755 |
1.42% |
positive regulation of interleukin-6 production |
GO:0044088 |
1.42% |
regulation of vacuole organization |
GO:0010324 |
1.42% |
membrane invagination |
GO:0008593 |
1.41% |
regulation of Notch signaling pathway |
GO:0010574 |
1.41% |
regulation of vascular endothelial growth factor production |
GO:0007218 |
1.41% |
neuropeptide signaling pathway |
GO:0048588 |
1.41% |
developmental cell growth |
GO:0009952 |
1.41% |
anterior/posterior pattern specification |
GO:0045472 |
1.41% |
response to ether |
GO:0007088 |
1.41% |
regulation of mitotic nuclear division |
GO:0010389 |
1.41% |
regulation of G2/M transition of mitotic cell cycle |
GO:0032768 |
1.41% |
regulation of monooxygenase activity |
GO:0035088 |
1.40% |
establishment or maintenance of apical/basal cell polarity |
GO:0098581 |
1.40% |
detection of external biotic stimulus |
GO:0030838 |
1.40% |
positive regulation of actin filament polymerization |
GO:0002221 |
1.40% |
pattern recognition receptor signaling pathway |
GO:0043304 |
1.40% |
regulation of mast cell degranulation |
GO:1903055 |
1.40% |
positive regulation of extracellular matrix organization |
GO:0031111 |
1.40% |
negative regulation of microtubule polymerization or depolymerization |
GO:0060021 |
1.40% |
roof of mouth development |
GO:0007417 |
1.39% |
central nervous system development |
GO:0002701 |
1.39% |
negative regulation of production of molecular mediator of immune response |
GO:0001937 |
1.39% |
negative regulation of endothelial cell proliferation |
GO:0046854 |
1.39% |
phosphatidylinositol phosphorylation |
GO:0006986 |
1.39% |
response to unfolded protein |
GO:0045992 |
1.39% |
negative regulation of embryonic development |
GO:0140115 |
1.39% |
export across plasma membrane |
GO:0008209 |
1.39% |
androgen metabolic process |
GO:0050851 |
1.39% |
antigen receptor-mediated signaling pathway |
GO:0006995 |
1.38% |
cellular response to nitrogen starvation |
GO:0033189 |
1.38% |
response to vitamin A |
GO:0032479 |
1.38% |
regulation of type I interferon production |
GO:0051289 |
1.38% |
protein homotetramerization |
GO:0007631 |
1.38% |
feeding behavior |
GO:0071514 |
1.37% |
genetic imprinting |
GO:0051482 |
1.37% |
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway |
GO:0008037 |
1.37% |
cell recognition |
GO:0060251 |
1.37% |
regulation of glial cell proliferation |
GO:0098815 |
1.37% |
modulation of excitatory postsynaptic potential |
GO:0019748 |
1.37% |
secondary metabolic process |
GO:0048863 |
1.37% |
stem cell differentiation |
GO:0072175 |
1.37% |
epithelial tube formation |
GO:0007617 |
1.37% |
mating behavior |
GO:0106070 |
1.36% |
regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO:0001906 |
1.36% |
cell killing |
GO:0072522 |
1.36% |
purine-containing compound biosynthetic process |
GO:0007369 |
1.36% |
gastrulation |
GO:0061436 |
1.36% |
establishment of skin barrier |
GO:0043470 |
1.36% |
regulation of carbohydrate catabolic process |
GO:0045671 |
1.36% |
negative regulation of osteoclast differentiation |
GO:0002573 |
1.36% |
myeloid leukocyte differentiation |
GO:0050853 |
1.36% |
B cell receptor signaling pathway |
GO:0030324 |
1.36% |
lung development |
GO:0045807 |
1.36% |
positive regulation of endocytosis |
GO:0060999 |
1.36% |
positive regulation of dendritic spine development |
GO:0031529 |
1.35% |
ruffle organization |
GO:0014850 |
1.35% |
response to muscle activity |
GO:0009595 |
1.35% |
detection of biotic stimulus |
GO:0035809 |
1.35% |
regulation of urine volume |
GO:1902253 |
1.35% |
regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
GO:0002082 |
1.35% |
regulation of oxidative phosphorylation |
GO:0014072 |
1.35% |
response to isoquinoline alkaloid |
GO:1904707 |
1.35% |
positive regulation of vascular smooth muscle cell proliferation |
GO:0032729 |
1.35% |
positive regulation of interferon-gamma production |
GO:1903725 |
1.35% |
regulation of phospholipid metabolic process |
GO:0034391 |
1.35% |
regulation of smooth muscle cell apoptotic process |
GO:0035813 |
1.35% |
regulation of renal sodium excretion |
GO:0043436 |
1.35% |
oxoacid metabolic process |
GO:2000193 |
1.34% |
positive regulation of fatty acid transport |
GO:0031645 |
1.34% |
negative regulation of nervous system process |
GO:0019229 |
1.34% |
regulation of vasoconstriction |
GO:0071071 |
1.34% |
regulation of phospholipid biosynthetic process |
GO:0030279 |
1.34% |
negative regulation of ossification |
GO:0006911 |
1.34% |
phagocytosis, engulfment |
GO:1901623 |
1.34% |
regulation of lymphocyte chemotaxis |
GO:0006575 |
1.34% |
cellular modified amino acid metabolic process |
GO:0019438 |
1.34% |
aromatic compound biosynthetic process |
GO:0001838 |
1.34% |
embryonic epithelial tube formation |
GO:0086009 |
1.33% |
membrane repolarization |
GO:0033280 |
1.33% |
response to vitamin D |
GO:0033032 |
1.33% |
regulation of myeloid cell apoptotic process |
GO:1902230 |
1.33% |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
GO:0045778 |
1.33% |
positive regulation of ossification |
GO:0060485 |
1.33% |
mesenchyme development |
GO:0030865 |
1.33% |
cortical cytoskeleton organization |
GO:0052192 |
1.33% |
movement in environment of other organism involved in symbiotic interaction |
GO:0050805 |
1.33% |
negative regulation of synaptic transmission |
GO:1903578 |
1.33% |
regulation of ATP metabolic process |
GO:1903844 |
1.32% |
regulation of cellular response to transforming growth factor beta stimulus |
GO:0006486 |
1.32% |
protein glycosylation |
GO:0009649 |
1.32% |
entrainment of circadian clock |
GO:2000648 |
1.32% |
positive regulation of stem cell proliferation |
GO:0034260 |
1.31% |
negative regulation of GTPase activity |
GO:0070085 |
1.31% |
glycosylation |
GO:0051438 |
1.31% |
regulation of ubiquitin-protein transferase activity |
GO:0003179 |
1.31% |
heart valve morphogenesis |
GO:0002823 |
1.31% |
negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0048524 |
1.31% |
positive regulation of viral process |
GO:0034219 |
1.31% |
carbohydrate transmembrane transport |
GO:0051028 |
1.31% |
mRNA transport |
GO:0046189 |
1.31% |
phenol-containing compound biosynthetic process |
GO:0035020 |
1.31% |
regulation of Rac protein signal transduction |
GO:2000406 |
1.31% |
positive regulation of T cell migration |
GO:2000278 |
1.30% |
regulation of DNA biosynthetic process |
GO:0090150 |
1.30% |
establishment of protein localization to membrane |
GO:0006479 |
1.30% |
protein methylation |
GO:0008213 |
1.30% |
protein alkylation |
GO:0018198 |
1.30% |
peptidyl-cysteine modification |
GO:0031214 |
1.30% |
biomineral tissue development |
GO:0043370 |
1.30% |
regulation of CD4-positive, alpha-beta T cell differentiation |
GO:0006338 |
1.30% |
chromatin remodeling |
GO:0006458 |
1.30% |
'de novo' protein folding |
GO:0030032 |
1.30% |
lamellipodium assembly |
GO:0048247 |
1.30% |
lymphocyte chemotaxis |
GO:0007035 |
1.30% |
vacuolar acidification |
GO:0110148 |
1.29% |
biomineralization |
GO:0002762 |
1.29% |
negative regulation of myeloid leukocyte differentiation |
GO:1990089 |
1.29% |
response to nerve growth factor |
GO:0043537 |
1.29% |
negative regulation of blood vessel endothelial cell migration |
GO:0009950 |
1.29% |
dorsal/ventral axis specification |
GO:0009651 |
1.29% |
response to salt stress |
GO:1905037 |
1.28% |
autophagosome organization |
GO:0009409 |
1.28% |
response to cold |
GO:0048762 |
1.28% |
mesenchymal cell differentiation |
GO:0046434 |
1.28% |
organophosphate catabolic process |
GO:0046320 |
1.28% |
regulation of fatty acid oxidation |
GO:0008366 |
1.28% |
axon ensheathment |
GO:0018022 |
1.28% |
peptidyl-lysine methylation |
GO:1902914 |
1.28% |
regulation of protein polyubiquitination |
GO:0072348 |
1.28% |
sulfur compound transport |
GO:0010677 |
1.27% |
negative regulation of cellular carbohydrate metabolic process |
GO:1900426 |
1.27% |
positive regulation of defense response to bacterium |
GO:0046637 |
1.27% |
regulation of alpha-beta T cell differentiation |
GO:1903580 |
1.26% |
positive regulation of ATP metabolic process |
GO:0032506 |
1.26% |
cytokinetic process |
GO:0015893 |
1.26% |
drug transport |
GO:0044728 |
1.26% |
DNA methylation or demethylation |
GO:0031018 |
1.26% |
endocrine pancreas development |
GO:0042364 |
1.26% |
water-soluble vitamin biosynthetic process |
GO:1900424 |
1.26% |
regulation of defense response to bacterium |
GO:0035107 |
1.26% |
appendage morphogenesis |
GO:0030534 |
1.25% |
adult behavior |
GO:0015749 |
1.25% |
monosaccharide transmembrane transport |
GO:0120162 |
1.25% |
positive regulation of cold-induced thermogenesis |
GO:0010758 |
1.25% |
regulation of macrophage chemotaxis |
GO:0052126 |
1.25% |
movement in host environment |
GO:0007632 |
1.25% |
visual behavior |
GO:0070193 |
1.25% |
synaptonemal complex organization |
GO:0002690 |
1.25% |
positive regulation of leukocyte chemotaxis |
GO:0002834 |
1.25% |
regulation of response to tumor cell |
GO:0006508 |
1.25% |
proteolysis |
GO:0043567 |
1.25% |
regulation of insulin-like growth factor receptor signaling pathway |
GO:0046636 |
1.24% |
negative regulation of alpha-beta T cell activation |
GO:0048525 |
1.24% |
negative regulation of viral process |
GO:0140238 |
1.24% |
presynaptic endocytosis |
GO:0098901 |
1.24% |
regulation of cardiac muscle cell action potential |
GO:0006110 |
1.24% |
regulation of glycolytic process |
GO:0006814 |
1.24% |
sodium ion transport |
GO:0043603 |
1.24% |
cellular amide metabolic process |
GO:0035019 |
1.24% |
somatic stem cell population maintenance |
GO:1904706 |
1.24% |
negative regulation of vascular smooth muscle cell proliferation |
GO:0006638 |
1.24% |
neutral lipid metabolic process |
GO:0001659 |
1.24% |
temperature homeostasis |
GO:0060047 |
1.24% |
heart contraction |
GO:2000369 |
1.24% |
regulation of clathrin-dependent endocytosis |
GO:0070169 |
1.23% |
positive regulation of biomineral tissue development |
GO:0006282 |
1.23% |
regulation of DNA repair |
GO:0046034 |
1.23% |
ATP metabolic process |
GO:0035264 |
1.23% |
multicellular organism growth |
GO:0042832 |
1.23% |
defense response to protozoan |
GO:0061028 |
1.23% |
establishment of endothelial barrier |
GO:0019731 |
1.23% |
antibacterial humoral response |
GO:0034502 |
1.23% |
protein localization to chromosome |
GO:1901136 |
1.23% |
carbohydrate derivative catabolic process |
GO:0010596 |
1.22% |
negative regulation of endothelial cell migration |
GO:0051646 |
1.22% |
mitochondrion localization |
GO:1901863 |
1.22% |
positive regulation of muscle tissue development |
GO:0060306 |
1.22% |
regulation of membrane repolarization |
GO:0043278 |
1.22% |
response to morphine |
GO:0014032 |
1.22% |
neural crest cell development |
GO:0048858 |
1.22% |
cell projection morphogenesis |
GO:0090598 |
1.22% |
male anatomical structure morphogenesis |
GO:0060966 |
1.21% |
regulation of gene silencing by RNA |
GO:0044770 |
1.21% |
cell cycle phase transition |
GO:0001773 |
1.21% |
myeloid dendritic cell activation |
GO:0048857 |
1.21% |
neural nucleus development |
GO:0098876 |
1.21% |
vesicle-mediated transport to the plasma membrane |
GO:0042552 |
1.21% |
myelination |
GO:0044271 |
1.21% |
cellular nitrogen compound biosynthetic process |
GO:0006826 |
1.20% |
iron ion transport |
GO:2000573 |
1.20% |
positive regulation of DNA biosynthetic process |
GO:0032967 |
1.20% |
positive regulation of collagen biosynthetic process |
GO:0060415 |
1.20% |
muscle tissue morphogenesis |
GO:0048635 |
1.20% |
negative regulation of muscle organ development |
GO:0048592 |
1.20% |
eye morphogenesis |
GO:0010614 |
1.20% |
negative regulation of cardiac muscle hypertrophy |
GO:0022618 |
1.20% |
ribonucleoprotein complex assembly |
GO:0060048 |
1.19% |
cardiac muscle contraction |
GO:0032655 |
1.19% |
regulation of interleukin-12 production |
GO:0034405 |
1.19% |
response to fluid shear stress |
GO:0048738 |
1.19% |
cardiac muscle tissue development |
GO:0032732 |
1.19% |
positive regulation of interleukin-1 production |
GO:0032731 |
1.19% |
positive regulation of interleukin-1 beta production |
GO:0006605 |
1.19% |
protein targeting |
GO:0006397 |
1.19% |
mRNA processing |
GO:0050852 |
1.19% |
T cell receptor signaling pathway |
GO:1905939 |
1.18% |
regulation of gonad development |
GO:1905606 |
1.18% |
regulation of presynapse assembly |
GO:0003156 |
1.18% |
regulation of animal organ formation |
GO:0046834 |
1.18% |
lipid phosphorylation |
GO:0051783 |
1.18% |
regulation of nuclear division |
GO:0035249 |
1.18% |
synaptic transmission, glutamatergic |
GO:0048146 |
1.18% |
positive regulation of fibroblast proliferation |
GO:0032787 |
1.18% |
monocarboxylic acid metabolic process |
GO:0018023 |
1.17% |
peptidyl-lysine trimethylation |
GO:0048521 |
1.17% |
negative regulation of behavior |
GO:0042059 |
1.17% |
negative regulation of epidermal growth factor receptor signaling pathway |
GO:0042447 |
1.17% |
hormone catabolic process |
GO:0006900 |
1.17% |
vesicle budding from membrane |
GO:0030042 |
1.17% |
actin filament depolymerization |
GO:0140029 |
1.17% |
exocytic process |
GO:0002920 |
1.17% |
regulation of humoral immune response |
GO:0048640 |
1.17% |
negative regulation of developmental growth |
GO:0007272 |
1.17% |
ensheathment of neurons |
GO:0007032 |
1.16% |
endosome organization |
GO:0006730 |
1.16% |
one-carbon metabolic process |
GO:0007007 |
1.16% |
inner mitochondrial membrane organization |
GO:0080171 |
1.16% |
lytic vacuole organization |
GO:0009642 |
1.16% |
response to light intensity |
GO:0071276 |
1.16% |
cellular response to cadmium ion |
GO:0035112 |
1.16% |
genitalia morphogenesis |
GO:1901797 |
1.16% |
negative regulation of signal transduction by p53 class mediator |
GO:0030890 |
1.16% |
positive regulation of B cell proliferation |
GO:1901099 |
1.16% |
negative regulation of signal transduction in absence of ligand |
GO:0042100 |
1.16% |
B cell proliferation |
GO:0046627 |
1.16% |
negative regulation of insulin receptor signaling pathway |
GO:0061512 |
1.16% |
protein localization to cilium |
GO:0008645 |
1.16% |
hexose transmembrane transport |
GO:0030857 |
1.16% |
negative regulation of epithelial cell differentiation |
GO:0008585 |
1.16% |
female gonad development |
GO:1901615 |
1.15% |
organic hydroxy compound metabolic process |
GO:0046173 |
1.15% |
polyol biosynthetic process |
GO:0090025 |
1.15% |
regulation of monocyte chemotaxis |
GO:0061951 |
1.15% |
establishment of protein localization to plasma membrane |
GO:0008544 |
1.15% |
epidermis development |
GO:0048260 |
1.15% |
positive regulation of receptor-mediated endocytosis |
GO:0043951 |
1.15% |
negative regulation of cAMP-mediated signaling |
GO:0006275 |
1.15% |
regulation of DNA replication |
GO:0001974 |
1.15% |
blood vessel remodeling |
GO:0070417 |
1.15% |
cellular response to cold |
GO:0042461 |
1.15% |
photoreceptor cell development |
GO:0045601 |
1.15% |
regulation of endothelial cell differentiation |
GO:0032922 |
1.15% |
circadian regulation of gene expression |
GO:1901361 |
1.15% |
organic cyclic compound catabolic process |
GO:0044242 |
1.15% |
cellular lipid catabolic process |
GO:0007033 |
1.15% |
vacuole organization |
GO:0042698 |
1.15% |
ovulation cycle |
GO:0032770 |
1.15% |
positive regulation of monooxygenase activity |
GO:0097028 |
1.15% |
dendritic cell differentiation |
GO:1901796 |
1.14% |
regulation of signal transduction by p53 class mediator |
GO:0000018 |
1.14% |
regulation of DNA recombination |
GO:0060322 |
1.14% |
head development |
GO:0030574 |
1.14% |
collagen catabolic process |
GO:0006259 |
1.14% |
DNA metabolic process |
GO:0051341 |
1.14% |
regulation of oxidoreductase activity |
GO:0035188 |
1.14% |
hatching |
GO:0002224 |
1.14% |
toll-like receptor signaling pathway |
GO:0050891 |
1.14% |
multicellular organismal water homeostasis |
GO:0051353 |
1.14% |
positive regulation of oxidoreductase activity |
GO:0042982 |
1.14% |
amyloid precursor protein metabolic process |
GO:0034440 |
1.13% |
lipid oxidation |
GO:0120039 |
1.13% |
plasma membrane bounded cell projection morphogenesis |
GO:0048704 |
1.13% |
embryonic skeletal system morphogenesis |
GO:0050830 |
1.13% |
defense response to Gram-positive bacterium |
GO:0051193 |
1.13% |
regulation of cofactor metabolic process |
GO:0110151 |
1.13% |
positive regulation of biomineralization |
GO:0040018 |
1.12% |
positive regulation of multicellular organism growth |
GO:0045600 |
1.12% |
positive regulation of fat cell differentiation |
GO:0045604 |
1.12% |
regulation of epidermal cell differentiation |
GO:0016569 |
1.12% |
covalent chromatin modification |
GO:0016570 |
1.12% |
histone modification |
GO:0044458 |
1.12% |
motile cilium assembly |
GO:0016049 |
1.12% |
cell growth |
GO:1904892 |
1.11% |
regulation of receptor signaling pathway via STAT |
GO:1903311 |
1.11% |
regulation of mRNA metabolic process |
GO:0006521 |
1.11% |
regulation of cellular amino acid metabolic process |
GO:0007030 |
1.11% |
Golgi organization |
GO:0010453 |
1.11% |
regulation of cell fate commitment |
GO:0000045 |
1.11% |
autophagosome assembly |
GO:0002673 |
1.11% |
regulation of acute inflammatory response |
GO:0006884 |
1.11% |
cell volume homeostasis |
GO:1905207 |
1.11% |
regulation of cardiocyte differentiation |
GO:0071711 |
1.11% |
basement membrane organization |
GO:0051146 |
1.11% |
striated muscle cell differentiation |
GO:0051952 |
1.10% |
regulation of amine transport |
GO:0032273 |
1.10% |
positive regulation of protein polymerization |
GO:0045823 |
1.10% |
positive regulation of heart contraction |
GO:0045197 |
1.10% |
establishment or maintenance of epithelial cell apical/basal polarity |
GO:0008154 |
1.10% |
actin polymerization or depolymerization |
GO:0014896 |
1.10% |
muscle hypertrophy |
GO:0060541 |
1.10% |
respiratory system development |
GO:0008361 |
1.10% |
regulation of cell size |
GO:1903313 |
1.10% |
positive regulation of mRNA metabolic process |
GO:0060148 |
1.10% |
positive regulation of posttranscriptional gene silencing |
GO:0002062 |
1.09% |
chondrocyte differentiation |
GO:0061640 |
1.09% |
cytoskeleton-dependent cytokinesis |
GO:0090224 |
1.09% |
regulation of spindle organization |
GO:0044703 |
1.09% |
multi-organism reproductive process |
GO:0006767 |
1.09% |
water-soluble vitamin metabolic process |
GO:0045071 |
1.09% |
negative regulation of viral genome replication |
GO:0071880 |
1.09% |
adenylate cyclase-activating adrenergic receptor signaling pathway |
GO:0002828 |
1.09% |
regulation of type 2 immune response |
GO:0007163 |
1.08% |
establishment or maintenance of cell polarity |
GO:0051186 |
1.08% |
cofactor metabolic process |
GO:0007628 |
1.08% |
adult walking behavior |
GO:0034330 |
1.08% |
cell junction organization |
GO:0033627 |
1.08% |
cell adhesion mediated by integrin |
GO:0048240 |
1.08% |
sperm capacitation |
GO:0033363 |
1.08% |
secretory granule organization |
GO:0021782 |
1.08% |
glial cell development |
GO:0001835 |
1.07% |
blastocyst hatching |
GO:0060041 |
1.07% |
retina development in camera-type eye |
GO:1901673 |
1.07% |
regulation of mitotic spindle assembly |
GO:0021675 |
1.07% |
nerve development |
GO:0009635 |
1.07% |
response to herbicide |
GO:0035024 |
1.07% |
negative regulation of Rho protein signal transduction |
GO:0007051 |
1.07% |
spindle organization |
GO:0071300 |
1.07% |
cellular response to retinoic acid |
GO:0045687 |
1.06% |
positive regulation of glial cell differentiation |
GO:0014912 |
1.06% |
negative regulation of smooth muscle cell migration |
GO:0034285 |
1.06% |
response to disaccharide |
GO:0031016 |
1.06% |
pancreas development |
GO:0032728 |
1.06% |
positive regulation of interferon-beta production |
GO:0033005 |
1.06% |
positive regulation of mast cell activation |
GO:0032814 |
1.06% |
regulation of natural killer cell activation |
GO:1903902 |
1.06% |
positive regulation of viral life cycle |
GO:0016571 |
1.06% |
histone methylation |
GO:0032196 |
1.06% |
transposition |
GO:0046839 |
1.06% |
phospholipid dephosphorylation |
GO:0035710 |
1.06% |
CD4-positive, alpha-beta T cell activation |
GO:0006855 |
1.06% |
drug transmembrane transport |
GO:0048278 |
1.06% |
vesicle docking |
GO:0007040 |
1.06% |
lysosome organization |
GO:0006631 |
1.06% |
fatty acid metabolic process |
GO:0008584 |
1.05% |
male gonad development |
GO:0044380 |
1.05% |
protein localization to cytoskeleton |
GO:0001944 |
1.05% |
vasculature development |
GO:0044706 |
1.05% |
multi-multicellular organism process |
GO:0022904 |
1.05% |
respiratory electron transport chain |
GO:1900076 |
1.05% |
regulation of cellular response to insulin stimulus |
GO:0048812 |
1.05% |
neuron projection morphogenesis |
GO:0030517 |
1.04% |
negative regulation of axon extension |
GO:0000281 |
1.04% |
mitotic cytokinesis |
GO:0055024 |
1.04% |
regulation of cardiac muscle tissue development |
GO:1905039 |
1.04% |
carboxylic acid transmembrane transport |
GO:0043487 |
1.04% |
regulation of RNA stability |
GO:0002263 |
1.04% |
cell activation involved in immune response |
GO:0071826 |
1.04% |
ribonucleoprotein complex subunit organization |
GO:1904659 |
1.04% |
glucose transmembrane transport |
GO:0030317 |
1.04% |
flagellated sperm motility |
GO:1901798 |
1.04% |
positive regulation of signal transduction by p53 class mediator |
GO:0043950 |
1.04% |
positive regulation of cAMP-mediated signaling |
GO:0007062 |
1.03% |
sister chromatid cohesion |
GO:0019835 |
1.03% |
cytolysis |
GO:0002218 |
1.03% |
activation of innate immune response |
GO:2000178 |
1.03% |
negative regulation of neural precursor cell proliferation |
GO:1902115 |
1.03% |
regulation of organelle assembly |
GO:0072595 |
1.03% |
maintenance of protein localization in organelle |
GO:0051656 |
1.03% |
establishment of organelle localization |
GO:1901137 |
1.03% |
carbohydrate derivative biosynthetic process |
GO:0021549 |
1.03% |
cerebellum development |
GO:0046879 |
1.03% |
hormone secretion |
GO:0016458 |
1.02% |
gene silencing |
GO:0046697 |
1.02% |
decidualization |
GO:0002286 |
1.02% |
T cell activation involved in immune response |
GO:0046626 |
1.02% |
regulation of insulin receptor signaling pathway |
GO:0033013 |
1.02% |
tetrapyrrole metabolic process |
GO:1905508 |
1.02% |
protein localization to microtubule organizing center |
GO:0071353 |
1.01% |
cellular response to interleukin-4 |
GO:0051580 |
1.01% |
regulation of neurotransmitter uptake |
GO:0072073 |
1.01% |
kidney epithelium development |
GO:1903825 |
1.01% |
organic acid transmembrane transport |
GO:1903432 |
1.01% |
regulation of TORC1 signaling |
GO:0086091 |
1.01% |
regulation of heart rate by cardiac conduction |
GO:0048488 |
1.01% |
synaptic vesicle endocytosis |
GO:0051972 |
1.01% |
regulation of telomerase activity |
GO:1900077 |
1.01% |
negative regulation of cellular response to insulin stimulus |
GO:0097722 |
1.01% |
sperm motility |
GO:0090162 |
1.01% |
establishment of epithelial cell polarity |
GO:0017145 |
1.01% |
stem cell division |
GO:0033238 |
1.01% |
regulation of cellular amine metabolic process |
GO:0015807 |
1.01% |
L-amino acid transport |
GO:0014048 |
1.00% |
regulation of glutamate secretion |
GO:0045662 |
1.00% |
negative regulation of myoblast differentiation |
GO:0016482 |
1.00% |
cytosolic transport |
GO:0051653 |
1.00% |
spindle localization |